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1. INTRODUCTION 
 Siddha system of medicine is an ancient indigenous medical system that has 
flourished on the Tamil soil over a span of more than hundreds and hundreds of years.  
This system of medicine is a complex of spirituality and healing technology that 
exploits herbal, metal, mineral substance, standing of course on tested theoretical 
foundations. 
 The traditional Tamil system of medicine should have existed from time 
immemorial even before the written history was made.  It is very difficult to say when 
it was exactly originated. 
 Even before 2000 years the monumental Tamil composition “Thirukural” 
gives a synoptic account of the basis of medical theory and practice in ten extremely 
condensed two line verses. 
  “மிகினும் குறையினும் ந஥ோய்செய்ம௃ம் நூந ோர்  
  வளிமுத ோ எண்ணிய மூன்று.” 
- திருக்குைள் 
As per the above verses Saint „Thiruvalluvar’ insisted that there are three 
Humours which regulates the body such as Wind, Fire and Flame, if any derangement 
of this three humours diseases will occur. 
 Siddhars were a disparate band of poet – philosophers with wide range of 
interests and capabilities.  Their compositions are replete with philosophies of life 
which are unorthodox and radical in nature.  Nevertheless, they are essentially men of 
medicine, and their philosophy is the philosophy of medicine.  Their compositions 
comprised profound insights into securing the health of human body and mind as 
well.  Their knowledge of the medical uses of a whole parts of herbs, metals and 
minerals should indeed so comprehensive and eclectic are their conceptions of 
medicine that they should not only make for a rewarding complement to all Synthetic 
drugs,  but give a new perspective to our philosophy of healing. 
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 The aim and goal of Siddhar is to attain perfection or a longevity life, were 
achieved through intellect or yoga. 
 Siddhar „Thirumular’ is one who practiced yoga to attain perfection.  
Konganavar, Chattaimuni, Karuvurar, Ramadevar says that those who try to worship 
God through the inner principle will attain perfection 
[1]
. 
 One of the basic concepts of Siddha system is that human body (Microcosm) 
and the cosmos (Macrocosm) are identical.  The cosmos is composed of 5 primordial 
elements (Pancha bhuthas). 
Thee (Fire) manifests in Neer (Water), Neer manifests in Vayu the activated 
wind, which manifests in Mann (Earth).  Mann and Katru (Wind) are interchangeable.  
These five primordial elements constitute the basis of everything.  The cosmos is 
composed of their conglomeration with open mindedness, one get things materialized 
through the aid of these primordial elements 
[2a]
. 
In this modern epoch many chronic diseases are due to lifestyle modification. 
One among the disease is the „Madhu megam‟ which is a great warning worldwide. 
The word „Madhu‟ means honey, the word „Megam‟ in the Siddha system is 
related to urine.  Hence, passing urine with sweetness is called „Madhumegam’.  The 
name Madhumegam is suitable for the symptoms of passing urine with sweetness.  
Siddhars have explained the 10 stages of Madhumegam called Aavathai and also the 
symptoms in each stage while mentioning about medicines for Madhumegam, they 
have prescribed both herbal and mineral preparations. 
 Diabetes mellitus is a metabolic disorder of multiple aetiology characterized 
by chronic hyperglycaemia with disturbance of carbohydrate, protein and fat 
metabolism resulting from defects in insulin secretion, insulin action, or both.
[2b]
  The 
major symptoms of Diabetes mellitus is increased thirst and hunger, frequent 
urination, weight loss, fatigue, skin infection etc.,    
It is explained in modern medicine that Diabetes Mellitus is caused by the 
ruining of beta cells in the Pancreas due to various cause by which the secretion of 
insulin is affected. 
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 In Siddha system, Kaya Kalpa medicines which can revive the beta cells 
secreting insulin have been explained.  This is a metabolic disorder, hence Kaya 
Kalpa medicines which can revive the ruined beta cells have been prescribed by the 
Siddhars long ago 
[3]
. 
PREVALENCE 
 Diabetes mellitus currently affects more than 62 million Indians, which is 
more than 7.1 % of Indians adult population.  An estimate shows that nearly 1 million 
Indians die due to Diabetes every year.  The average age of onset is 42.5 years. 
 In 2014, India topped the world with the highest number of people with 
Diabetes Mellitus.  The prevalence of Diabetes is predicted to double globally from 
170 million in 2000 to 366 million in 2030 with a maximum increase in India.  It is 
predicted that by 2030, Diabetes mellitus may afflict upto 79.4 million individuals in 
India.   
 India currently faces an uncertain future in relation to the potential burden that 
Diabetes may impose upon the country.  Many influences affect the prevalence of 
disease throughout a country and identification of those factors is necessary to 
facilitate change when facing health challenges.  So what are the factors currently 
affecting Diabetes in India that are making this problem so extreme. 
 The aetiology of Diabetes in India is multi-factorial and it includes genetic 
factors coupled with environmental influences such as obesity associated with rising 
living standard, steady urban migration and lifestyle changes.  Yet despite the 
incidence of Diabetes within India, there are no nationwide and few multi-centric 
studies conducted on the prevalence of Diabetes and its complications.  The studies 
that have been undertaken are also prone to potential error as the heterogeneity of the 
India population with respect to culture, ethnicity, socio – economic condition means 
that the extrapolation of regional results may give inaccurate estimates for the whole 
country. 
 Rough estimation show that the prevalence of Diabetes in rural populations is 
one quarter that of urban population for India and other Indian sub-continent countries 
such as Bangladesh, Nepal, Bhutan, Sri Lanka etc 
[4]
. 
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Mortality and morbidity rate 
 Estimated 24 million persons with Diabetes in India in 2000 and this number 
is predicted to rise to almost 70 million people by 2025. The country with the largest 
number of Diabetic people will be India. 
 In recent study in Chennai, nearly 25% of population was unaware of a 
condition called Diabetes 
[5]
. 
 
The world wide mortality  of these disease Diabetes should be as follows 
South Africa – 91.67, Mexico – 89.56, Indonesia – 58.79, Sri Lanka – 47.87, 
Australia – 15.84, Malaysia – 23.86, India – 25.40, China – 14.80 and United state – 
14.78 
[6]
. Hence, Diabetes mellitus is a life style disorder, which is a problem faced 
majorly by the world today. 
 Siddha medicine is a eccentric one, it is not only a curative, but also 
preventive. It helps to achieve the healthy body and also mind. Siddha medicines 
rejuvenate the body.  
 Siddhars have contributed numerous herbo mineral preparations through their 
literature. Siddhars obtained the products from nature. According to Siddha Materia 
Medica the medicines are obtained from herbs, metals, minerals and animals products.  
Siddha system of medicine has numerous numbers of formulations for various 
diseases. Siddha medicine plays an effective role in treating Diabetes mellitus. In the 
use of synthetic drugs, too many adverse drug reactions like Cardiovascular disease, 
neuropathy, nephropathy, retinopathy, foot damage, skin changes, Alzheimer‟s 
disease etc., may occur and the long term course of drug is some time fatal. 
Hence, there is a need for the new drugs formulation for these major problems, 
which should be less toxic, low cost and short term use. Here the drug “Linga 
Mathirai” is considered to satisfy the above need, and is a unique herbo mineral 
formulation against Diabetes mellitus.  
Based on the above fact, an attempt was made to validate the Siddha herbo 
mineral formulations of “Linga Mathirai” for its Anti-diabetic, Anti-dyslipidemic 
activity in animal models and Anti-oxidant activity in DPPH assay. 
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2. AIM AND OBJECTIVES 
Aim 
 Diabetes mellitus is a metabolic disorder and now it is a lifestyle disorder 
which is a great threat to the mankind. As there is a great change in our day to day 
activities, food habits, physical activities etc., this disease has got its own spurt 
worldwide. Particularly India is the leading one as it is getting more westernized. This 
disease needs treatment with safe medication and quality living. This could be 
achieved by Siddha system of medicine as it not only treats the disease but also brings 
the overall wellbeing of the human. 
 According to the Siddha literature Linga Mathirai was used for Diabetes 
mellitus. Thus the aim of this study was to validate the safety and efficacy of the test 
drug Linga Mathirai for Anti-Diabetic Activity in Streptozotocin induced Wistar 
albino rats. 
Objectives 
The following methodology was adopted to evaluate the safety and efficacy of the 
test drug in this study 
 Collection of various Siddha and modern literature relevant to the study. 
 Preparation of the drug according to the classical Siddha literature. 
 Evaluate Physico chemical, bio-chemical analysis to standardization the test 
drug. 
 To estimate the percent of elements, functional groups and particle size through 
instrumental analysis of the trial drug. 
 Evaluation of the Acute and 28 days repeated dose Toxicity of test drug 
according to OECD guidelines. 
 Evaluation of pharmacological study of the drug through the following: 
 Anti-Diabetic Activity-Streptozotocin induced diabetes in Wistar albino 
rats. 
 Anti-Dyslipidemic Activity-Triton WR 1339 induced Dyslipidemic in 
Wistar albino rats. 
 Anti-Oxidant Activity-Through DPPH assay  
 To scrutinize all the above studies to establish the potency of Linga Mathirai. 
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3. REVIEW OF LITERATURE 
3.1.  DRUG REVIEW 
3.1.1.  SIDDHA ASPECT 
INGREDIENTS OF LINGA MATHIRAI 
 Lingam (Cinnabar)  
 Sivanar vembu (Indigofera aspalathoides) 
 Naabi (Aconitum ferox) 
 Nalla Ennai (Sesame oil) 
LINGAM 
[7]
  
Metonymy:    Inkuligam, Raasam, Kadaivanni Karppam, Kalikkam, Kaanjanam, 
Kaaranam, Saaniyam, Chendooram, Maniragam, Milecham, Vani and Vanni.   
   
“நணியாரி இங்கு஬ிகம் யன்சாதி஬ிங்கம் 
தணியாபேம் கார்குணம் சாபேம்-஧ிணிநால஬ 
தாழ்ந்த ஧யி கும஬ாய்த் தாங்காத் திரிததாடம் 
யழீ்ந்தான்றும் என்த஫ யி஭ம்பு...” 
- அகத்தினர் [8]   
“யன்஦ினின் ககர்ப்஧ நகத்தா஦ உண் 
கன்஦ின க஧பேநான் காபணநாம்  ஬ிங்கம் 
தன்஦ிச்ச நபசம் சார்யா஦  கசந்தூபம் 
அன்஦ிப் ஧ி஫ந்திடும் ஬ிங்கத்தின் க஧னதப....” 
- சட்டப௃஦ி [9]   
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“நல஬யாரி நல஬பாசம் நணி஥ாகம்” [10] 
Vernacular Names  
        Sanskrit - Lingam 
Telugu  - Inglieekam 
Kannada - Chayilyam 
Hindi  - Hingool  
 Properties 
                It is hard; it fumes when it exposed to fire; not soluble in water; has no 
smell and taste. 
Suvai (Taste)   : Tasteless 
Thanmai (Nature)  :  Veppam 
Action:-  Tonic 
General character 
  த஧திசுபஞ் சந்஥ி க஧பேயிபண ஥ீகபாடுத 
  காதகடி காசங் கபப்஧ான்புண்- தணாத  
  வுபேயி஬ிங்க சங்கதநா பெறுகட்டி ப௅ம்த஧ாங்  
  குபேயி஬ிங்க சங்கநத்லதக் ககாள். 
  ஆதி னிபதவுக் காத஬ாற் சாதி஬ிங்க 
  தநாதி ஬ிபதகுண ப௃ற்றூட஬ிற்-஫தீுபுரி 
  குட்டங் கிபந்தி ககாடுஞ்சூல஬ யாதப௃த 
  ற௃ட்டங்கு த஥ாய்கல஭தனாட் டும். 
- குண஧ாடம் தாது சீய யகுப்பு  
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              Lingam is effective in the treatment of Diarrhoea, Pyrexia, Delirium, 
Urticaria, Diuresis, Tuberculosis, Scabies, Syphilis, Leprosy, Eczema, Skin diseases, 
Throbbing pain (Soolai) and vatha diseases. 
Purification 
 Lingam can be purified by many methods as follows. 
1. 1400 gm of Alangium bark (Alangium salvifolium) is powdered and added 
with 5.2ltrs of rice vinegar in the pot and placed it in the dew at night. The 
next day, it is kindled well.  35grms of Lingam is tied well in a cotton cloth 
and put it into the above liquid. The pot is covered with lid and sealed with 
mud pasted cloth, it is dried and exposed in the dew for one day. Then they are 
heated with low intensity flame until the liquid is completely evaporated. The 
Lingam is taken out and cleaned well. This procedure is repeated with the 
whole plant of Vitis lanata (Pulikarunai) and the root of Hemidesmus indicus 
(Nannari).  
  கசால்஬க்தகள் பு஬த்தினத஦ நகத஦ னிந்தத் 
   துல஫னா஦ சாதி஬ிங்க சுத்தி தாத஦ 
  கயல்஬க்தக  ஭மிஞ்சில் பு஭ிங்கபேலண தனாடு 
   தந஬ா஦  ஥ன்஦ாரிக் காடித் தண்ணரீ் 
  புல்஬க்தக ஭தித஬ார் ப௄ன்று லயகல் 
   புலகனாநல் யி஭க்கிக஬ரி னழுக்கு ஥ீங்கும் 
  கயல்஬க்தக ஭஭வுகதாடிக் ககான்த஫ யலீச 
   கயறுந் தண்ணரீ் ஥ாற௃஧டி யதீ நாதந.  
- குண஧ாடம் தாது சீய யகுப்பு 
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2. Lime juice, cow‟s milk and the Indian Acalypha juice are mixed in equal 
proportion and allowed to process Lingam so as to get it in a consolidated 
potency state. 
3. When the crude form of Lingam is soaked for one day in mother‟s milk and 
lemon juice respectively, it becomes purified.   
4. Lingam is soaked in mother‟s milk for 30 naazhigai (30×24=720 mins). It is 
removed and again fresh milk is added and the process is repeated for two 
times. 
Toxic symptoms of Lingam 
 Loss of taste, difficulty in eating and drinking water.  
 Ulcers in the buccal floor, Uvula (base of the mouth), inner portion of the 
tongue,    larynx and large intestine.  
 Foul odour from the mouth, discharge is viscous, whitish saliva.  
 Difficult to speak and burning sensation are the toxic features of Lingam. 
Antidote 
[11]
 
 Nutmeg (Myristica fragrans) 
 Cubeb pepper (Piper cubeba)  
 Root bark of red cotton tree (Gossypium arboreum)  
 Sugar                                                                      
 All the above ingredients were taken equal quantity of 4.2gm are made into a 
decoction and administered twice a day for 48 days. 
1. SIVANAR VEMBU [12a]  
Other name: Kandhari 
Vernacular name:  
 Malayalam -  Manaveli 
 Sanskrit -  Shivanil 
 Kan   -  Shivamalli-gida 
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Properties 
 Suvai (Taste)  :  Kaippu 
 Thanmai (Nature) :  Veppam 
 Pirivu (Division) :  Kaarppu 
Action:-  Antiseptic, Stimulant, Demulcent and Disinfectant. 
General character 
  “குட்டஞ் சிபங்கு குல஫ப்புப் ஧ிசநாந்லத 
  கட்டப் ஧ிணிகள் கமற௃தந – திட்டம் 
  உப஦ிம்஧ங் கானத்துக் குண்டாகு தநல஬ 
  அப஦ிம்஧ கநன்னுநபேந் தால்.” 
- ததலபனர் [13] 
Uses
 [14a]
 
 The leaves, flowers and tender shoots are said to be cooling and demulcent 
action. They are employed as decoction in leprosy and cancer, elephantiasis 
and alternative in Secondary Syphilis. 
 The root is chewed as a remedy for tooth ache. 
 The whole plant is grinded with butter and applied to reduce oedematous 
tumors. 
 A preparation is made from the ashes of the burnt plant to remove dandruff . 
 The leaves are applied to abscesses; and oil is obtained from the root which is 
used to anoint the head in erysipelas. 
 This is one of the important ingredients of the specific oil for syphilitic and 
other skin diseases.   
 A decoction of the entire plant is given as an alternative in Secondary Syphilis, 
Psoriasis etc. 
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2. NAABI [12b] 
Other name: Vashanabi, Vidam, Marutham. 
Vernacular name 
 Mal   -  Vatsanabhi 
 Tel  -  Vatsanabhi 
 Assam  -  Bish 
 Hin   -  Bachhnag 
 Sans  -  Vatsanabi 
 Kan  -  Vatsa- nabhi 
Properties 
 Suvai (Taste)  :  Kaippu 
 Thanmai (Nature) : Veppam 
 Pirivu (Division) :  Kaarppu 
Action:-  Diaphoretic, Diuretic, Anodyne, Antipyretic, Narcotic, Sedative. 
General character 
  “யாதய஬ி நந்தந஫ல் நா஫ாக் க஧ப்஧ிணிகள் 
  ஓதுகுட்டு குன்நந்ததள் ஓடுங்காண் – காத஬ர்தம் 
  புத்திதனா டாபேனிபேம் பூவும் யல஭குமத஬ ! 
  சுத்திகசய்த ஥ாயினின்த஧ர் கசால்.” 
- அகத்தினர் [15]   
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Purification  
The root is treated with urine or milk from the cow or with cow dung for three 
or more days.  The urine,  milk or dung being renewed every day.  
Uses
 [14b]
 
 Removes “Vatha” and “Kapha” alleviates inflammatory throat complaints 
and fevers, stimulates the secretion of bile, a general remover of internal 
inflammation. 
 Eighteen varieties of which ten are very poisonous.  Used in leprosy and 
inflammatory complaints of the throat and lungs.  
 It is a very effective medicine in various diseases acting as a narcotic, 
sedative and stimulant.  Useful in fever, cephalalgia, infections of the throat, 
dyspepsia and rheumatism. 
 Internally, it is chiefly used in the treatment of chronic intermittent fevers.  
The drug is chiefly employed in India in the treatment of leprosy, fever, 
cholera and rheumatism. 
 A Preparation of the root is much used in all the hilly districts in India to 
poison arrows.  The toxic principle is the alkaloid pseudaconitine. 
 Tincture of aconite at first slows the heart rate, lowers the blood pressure 
and increases the peripheral circulation, later the heart rate is accelerated 
and the blood pressure is raised. 
 After treatment of the root with cow‟s urine the tincture increases the rate 
and systole of the heart, the blood pressure and the peripheral circulation, 
and the effects persist for a very long time (K.C. Bose, Mhaskar and Caius). 
 If the root is treated with cow‟s milk, instead of urine, the above changes are 
much more pronounced  (Mhaskar and Caius). 
 The crude root contains about 14% of total alkaloids, whereas the root 
treated with cow‟s urine and exposure to sunlight have brought about a 
partial change of the toxic alkaloids aconitine and pseudaconitine into far 
less poisonous substances benzoyl-aconine and veratroyl-aconine (K.C. 
Bose). 
 
 REVIEW OF LITERATURE 
 
13 
ANTI DIABETIC ACTIVITY OF LINGA MATHIRAI 
3. NALLA ENNAI 
Other name: Thilam 
Vernacular name 
 Tel -  Nuvulu 
 Mal -  Karuella 
 Eng -  Gingelly oil plant 
 Sans -  Tilam 
 Kan -  Ellu 
 Hin -  Thil 
Properties 
 Suvai (Taste)  :   Inippu 
 Thanmai (Nature) :  Veppam 
 Pirivu (Division) :  Inippu 
Action:- Demulcent, Laxative, Nutritive, Emollient. 
General Character 
  “புத்தி஥ன஦க் கு஭ிர்ச்சி பூரிப்பு கநய்ப்பு஭கஞ் 
  சத்துயங் கந்தி த஦ினி஭லந – கநத்தவுண்டாங் 
  கண்தணாய் கசயித஥ாய் க஧ா஬யமல் காசத஥ாய் 
  புண்தணாய்த஧ா கநண்கணய்னாற் த஧ாற்று. ” 
- அகத்தினர் [15b]   
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 The seeds are acrid with a sharp bitter sweet taste, oleagenous, toxic, cooling, 
galactagogue, diuretic, astringent to the bowels, aphrodisiac. 
Promote the growth of hair, useful in diarrhoea, gouty joint, urinary 
concretions, eye disease, applies to ulcers and piles cause “Kapha” and biliousness. 
 The oil from the seeds are strengthening, useful in dry cough, asthma, diseases 
of the lungs, burning sensation while micturation, diseases of the ear and eye, scabies, 
smallpox, gouty joints, syphilitic ulcers, inflammations. 
 In Ceylon, the oil is used for cooling the body.  The seeds pounded with 
Jaggery are taken to purify the blood
 [14c]
. 
 In South Africa, natives use the seed as an aphrodisiac. 
 Sushruta prescribes the leaves in the treatment of snake bite and scorpion 
sting. 
3.1.2.  MODERN ASPECT OF DRUGS  
1. CINNABAR [16] 
Metonymy 
        Cinnabarite, Vermillion, Vermilion Chinna red. 
Introduction 
  Cinnabar is the chief mineral composed of the element of mercury and is very 
important ore of mercury. It is a colourful mineral that adds a unique colour to the 
mineral colour palette.  The term is also used to describe the bright red colour of this 
element. 
Occurrence 
       It occurs in many parts of world, particularly in California, China, Spain, Italy 
&United States.  
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General properties 
Table 1:- Physical properties Cinnabar 
Colour Bright scarlet red or brick red  
Luster Adamantine to sub metallic in darker specimens 
Transparency Crystals are translucent to transparent  
Crystal system Hexagonal 
Hardness 2 to 2.5 
Specific gravity 8 to 8.1 
Associated minerals Pyrite, quartz, mercury and Dolomite, calcite. 
    
Table 2:- Chemical properties of Cinnabar 
Chemical formula HgS 
Composition Mercury (II) sulfide  
 1)  86.22% - mercury (Hg) 
 2)  13.78%  - sulfide (S) 
 
   HgS  which has long been used in combination with traditional Siddha & 
Chinese medicine as a Sedative, hypotonic, ant- inflammatory ,anti pyretic & 
analgesic for more than 2000 years and is still widely used in Asian countries. 
The estimated human therapeutic dose of cinnabar in traditional medicine used 
to approximately 5 -25 mg /kg /day /per dose three times / day as indicated.  
  An overdose of cinnabar in drugs such as Bapuslsan, which is used as a 
sedative & for management of external intoxication  in the Chinese population. 
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    It must be aware of its toxic effects due to high mercury content. Previous 
studies have shown that the insoluble form of HgS (or) cinnabar can still be absorbed 
from GIT and liver.  
Uses 
 Cinnabar is to be used commonly because of its physical properties in the art 
work of ancient times due to its interesting red colour.  
 It is used in the making of instruments; traditionally it was used to recover gold 
sediments or streams and in used as a fungicide. 
 It is the principle ore of mercury.  So the mercury is removed from this rock 
and used in the instruments such as thermometers and such. 
 It was also used as a powder called vermilion, which in small amounts could be 
used as food colouring. 
 Medicinal Uses 
 Cinnabar is grinded with lemon juice for 3hours. It is extremely efficacious 
drug in liver disorder such as commencing cirrhosis of liver, dyspepsia, chronic 
dysentery and similar other allied diseases like chronic diarrhoea. 
 In secondary syphilitic eruptions, a powder composed of two parts of cinnabar 
is used for fumigation. 
 An ointment of cinnabar is applied to bring about the resolution of buboes. 
 In Meta physical ore, cinnabar has positive effects on the immune system and 
blood. 
Toxic symptoms of Cinnabar
 [17]
 
Most of the soluble salts of mercury are absorbed slowly from the intestinal 
mucous membrane of the alimentary tract and produce their toxic effects.  
After the absorption mercurial salts are excreted into the caecum and colon as 
sulphides, in this form the mercury is found in the fecal matter. 
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The long term use of cinnabar contained in traditional medicines could result 
in renal dysfunction due to accumulation of mercury in kidney. 
Blurred vision due to accumulation of mercury in brain is possible. 
Skin allergic reaction may occur when cinnabar is used in tattoo dyes. 
BOTANICAL ASPECT 
2. Indigofera  aspalathoides [18] 
Classification 
  Kingdom :  Plant Kingdom 
  Class  : Dicotyledons 
  Sub class :  Polypetalae 
  Series  : Calyciflorae 
  Order  : Rosales 
  Family  :  Leguminosae 
  Sub family :  Fabaceae 
  Genus  : Indigofera 
  Species :  aspalathoides 
Distribution  
Plains of Karnataka and Ceylon.  
The common habitat of Indigoferaaspalathoides is dry sandy place.  It may 
grow well near the coastal regions 
Morphology 
The plant is a sub shrub and grows erect.  The young branches are 
characteristically purple with dense covering of minute trichomes.  The leaf is 
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trifolliolate and sessile.  The flowers are purple, solitary and axillary, the pods are 
straight and cylindrical with sparse trichomes, and seeds are cuboidal and smooth.  
Analysis of the leaves and stems 
 Water   :  80.5% 
 Protein   :  3.1% 
 Fat   : 0.4% 
 Soluble CHO  : 6.4% 
 Fiber   : 2.8% 
 Nutritive ratio  : 3.3% 
 Starch equivalent :  12.916/100 
 The leaves and stems constitute a source of vitamin A and C. 
Phytochemical investigation has revealed the presence of many compounds that are 
biologically active such as salicylic acid, B-sistosterol-gluco puranoside and 
crythroxydiols „X‟ and „Y‟. 
3. Aconitum ferox 
Vernacular name 
  Kingdom :   Plantae 
  Class  :  Eudicots 
  Order  :  Rananculales 
  Family  :  Rananculaceae 
  Genus  :  Aconitum 
  Species :  ferox 
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Distribution 
 Alpine Himalaya of Nepal  
Morphology 
 Roots biennial, paired, tuberous, daughter – tuber ovoid – oblong to ellipsoid, 
stem is erect, with or without a slender, hypogaceous base which emits numerous fine 
roots near the upper end, simple, erect
 [19]
. 
 Leaves scattered, distant excepting the lowest 2 or 3 which are usually 
decayed at the time of flowering.  Inflorescence a loose raceme. 
Chemical Constituents 
 The total alkaloid content in commercial Aconitum ferox varies from 0.63% to 
4.7%.  Pure roots of Aconitum ferox contain the alkaloids pseudaconitine, 
chasmaconitine, indaconitine and bikhaconitine, recently two new alkaloids veratroyl 
pseudaconitine and diacetyl pseudaconitine
 [20]
. 
 The use of aconite in criminal cases and for homicidal purposes is well known. 
4. SESAME OIL 
 Sesame oil is known as the “Queen of Oils”, it is obtained from the seeds of 
Sesamum indicum plant. 
 Sesamum is one of the most ancient of cultivated crops in India.  It is the first 
oil seed cultivated by man.  Sesamum seed has been an essential article in Hindu 
religious ceremonies and has been referred to as Homodharya and Pitrutarpana in 
ancient scripts.  Sesame seeds yield on expression edible oil
 [21]
. 
Constituent of Sesame oil 
 The Glycerides composition of the oil appears to be less effected by climatic 
and other factors during growth of the crop. 
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Fatty acid Composition 
Unsaturated Fatty Acid 
  Mono unsaturated Fatty Acid (Oleic acid) -  41% 
  Poly unsaturated Fatty Acid (Linoleic acid) -  45 % 
 Saturated Fatty Acid 
  Palmitic Acid     -  9 % 
  Stearic Acid     -  5 % 
Other Chemical Composition 
 Sesame seeds contain 50 – 60% of fatty oil which is characterized by two 
lignases are Sesamin and Sesamolin.  Two phenolic antioxidants are gained during 
raffination. 
 Unsaponifiable matter  -  1.5 – 2.3%. 
 Total sterols   -  0.35 – 0.54%  
Free sterols   -  0.20 – 0.24 % (β-sistosterol). 
 Phospholipids   -  0.034 – 0.132 %,  
Lecithin   -  52%  
  Cephalin   -  40.6 % 
 δ – Tocopherol, lignins, calcium are also present. 
Uses 
1. Sesamol and Sesaminol 
 Maintain fats (LDL and HDL) 
 Promote integrity of body tissues. 
 Enhances Vitamin E activity to provide antioxidant capacity to the 
body. 
 Sesamin promotes a balanced immune and auto immune response. 
 δ – Tocopherol has little Vitamin E activity. 
 Lignins promote healthy liver. 
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2. Sesame oil: 
 Is a cell growth regulator and slows down cell growth and replication.  
 Is used as healing oil for thousands of years, used after exposure to 
wind or sun, it will calm burns. 
 Is a natural anti inflammatory agent. 
 Retains and contain calcium which is an important nutrient for entire 
vascular system. 
 Helps maintain normal fat level. 
 It used in the treatment of diabetes, hepatitis and migraine. 
 Used before and after radiation treatment, sesame oil helps neutralize 
the flood of oxygen radicals. 
 Is naturally antibacterial for common skin pathogens as 
Staphylococcus and Streptococcus as well as common skin fungi such 
as athlete‟s foot fungi and gingivitis. 
 Is naturally antiviral. 
 In Vitro, sesame oil inhibited replication of Human Cancer cells. 
 In both small intestine and colon, some are nourished by fat instead of 
sugar and the presence of sesame oil can provide the cells with 
essential nourishment. 
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3.2.  DISEASE REVIEW 
3.2.1.  SIDDHA ASPECT OF THE DISEASE 
MADHUMEGAM  
Madhumegam comes under Neerinai Perukkal Noi as mentioned in Therayar Maha 
Karisal. 
 “஥ீரிபேயில஦க் குணத்லத ஥ீன஫ியிரித்துச் கசால்யாம்  
 ஥ீரில஦ப் க஧பேக்கக஬ான்று ஥ீரில஦னபேக்க க஬ான்று  
 ஥ீரிமிவுடத஦ ககால்ற௃ம் ஥ீர்க்கட்டு யில஦கக஭ன்று  
 ஥ீணி஬ப௃ல஫க் குநிந்த ஥ீர்஥ில஫க் குணத்லதக் தக஭ாய் .” 
- ததலபனர் [22] 
Synonym 
Mega neer, Vegu moothiram, Innipu neer, Neerizhivu, Thithippu neer, 
Pramegham. 
Definition
[23]
 
Madhumegam is a clinical condition characterized by frequent urination 
resulting in deterioration and diminution of seven thathus and loss of weight.
 
 
Abdomen distends, slurring of speech, peripheral neuritis, lassitude, dyspnoea 
are the symptoms of Madhumegam. 
Etiology 
 Diet habits 
 Sexual indulgence 
 obesity 
 Psychosomatic cause 
 Hereditary 
 Excess stimulation of moolatharam 
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General symptoms
 
 
 1. Thirst                                        8.  Polyuria 
 2. Polydipsia                                 9. Cough 
 3. Anorexia                                 10. Dyspnoea 
 4. Delirium                                  11. Pain in the hip and burning sensation 
 5. Sleeplessness                           12. Loss of Weight 
 6. Hiccough                                 13. Flatulence 
 7. Anaemia                                  14. Giddiness 
Classification of the disease 
Classification of Megam
 [24]
 
             Vali - 4                    Iyam - 10 
1. Neimananeer     1.Iyaneer               
2. Pasumananeer    2.Thuimaineer 
3. Seezhmananeer                                          3.Moolaineer  
4. Sadhaimanane    4.Ilaneer 
Azhal – 6     5.Ulneer             
1. Yanaikozhupu Mananeer   6.Thavalaneer 
2. Katrazhai Mananeer    7.Kazhuneer 
3. Chunna Mananeer    8.Thenneer 
4. Ennipu Megam    9.Uppuneer 
5. Palingu Neer     10.Kavichuneer 
6. Muyal Kuruthi Neer 
Diabetes mellitus is a clinical entity in a modern medicine is closely resembles 
one of the types of “Pitha Premeham” i.e “Madhumegam”. 
Clinical features 
Polyuria, polyphagia, polydipsia, perspiration, exhaustion, insomnia, giddiness 
and loss of weight even at normal consumption of food. 
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Pathophysiology
 [25]
 
       In the disease Madhumegam, due to internal and external causes affect balance in 
the ratio of Vali, Azhal, and Iyam. The imbalance affects the Keelnokkukal, which in 
turn affect the seven Udal thathukkal. Saram gets affected and there is loss of 
appetite. Seiner also get affected with the net result even if the patient eats more 
nourished food (Polyphagia), there won‟t be any improvement in health. 
An imbalance in Iyam does imply an imbalance in other two kutrams too and 
causes derangement of dasavayu and seven Udal thathukkal which causes the disease 
and other complications. 
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3.2.2.  MODERN ASPECT OF THE DISEASE 
Diabetes mellitus 
Diabetes mellitus is one of the most common endocrine disorders. It is a 
clinical syndrome characterized by hyperglycaemia with or without glycosuria, 
resulting from an absolute or relative deficiency of insulin, affecting carbohydrate, 
protein and fat metabolism. It may be due to impairment of insulin production or its 
release by Beta cells of islets of Langerhans. Long standing metabolic derangement is 
associated with functional and structural changes in many organs especially the 
vascular system leading to Diabetic retinopathy, neuropathy and nephropathy and 
atherosclerosis. 
The three major types of Diabetes mellitus 
 Type 1 Diabetes. 
 Type 2 Diabetes. 
 Gestational Diabetes mellitus 
Type 1 diabetes mellitus 
 It is called as the insulin dependent, immune mediated or juvenile onset 
diabetes. People with this type of diabetes produce very little or no insulin. They need 
injections of insulin everyday to control the glucose level in the blood. 
Type II diabetes 
 It is called as the non-insulin dependent diabetes. It is also known as late-onset 
diabetes and it is characterized by insulin resistance and relative insulin deficiency. 
Though the disease is highly genetic in origin some risk factors such as excess weight, 
inactivity, high blood pressure and poor diet plays a major role for its development.  
Gestational Diabetes mellitus (GDM) 
 It is the presence of high glucose level in the blood during pregnancy. It 
usually disappears after the pregnancy but the women and her children are at high risk 
of developing type II diabetes later in their life. 
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Complications
 [26]
 
 Virtually every tissue and organ is biochemically and structurally altered as a 
consequence of the hyperglycemia of diabetes and result in complications.   
 Two biochemical mechanisms appear to be involved in the development of 
many complications.    
(i) Non enzymatic glycosylation  
 It is the process by which glucose attaches to amino group of proteins without 
the aid of enzymes. That can cause structural and functional abnormalities of the 
involved proteins to form Advanced Glycation End Products (AGE), which cause 
microangiopathy, nephropathy. The concentration of Glycosylated Hemoglobin 
(HbA1C) in the blood is now used clinically as a measure of therapeutic control. 
(ii) Intracellular Hyperglycaemia with disturbances in Polyol pathways  
 The second biochemical mechanism operates in the aorta, lens of the eye, 
kidney and peripheral nerves.  These tissues are endowed with an enzyme, aldoses 
reductase that facilitates the accumulation of sorbital and fructose in cells of the 
hyperglycemic patient.  As a result of the intracellular accumulation of sorbital and 
fructose an osmotic gradient is established and excessive amounts of water enter the 
cells from the extra cellular compartment.  The cells then swell and are damaged and 
contribute to neuropathy and cataracts.    
1. Diabetic ketoacidosis        
 It is a major medical emergency and serious cause of mortality principally in 
people with type 1DM.  It has a mortality rate of 6-10%.In newly diagnosed patients 
of type 1 DM there is failure of endogenous insulin and in NIDDM it is due to 
inadequate exogenous insulin or a stressful conditions like myocardial infarction, 
hyperthyroidism, pheochromocytoma, trauma, pregnancy, drugs like cocaine. In these 
conditions there is increase in production of counter regulatory hormones like 
epinephrine, cortisol, glucagon and growth hormone.    
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The cardinal biochemical features are          
  1.Hyperglycaemia      
  2.Hyperketonaemia       
  3.Metabolic acidosis 
Clinical features
 [27] 
         
 (i)  Polyuria, thirst, weight loss, weakness, nausea, vomiting, leg cramps, 
blurred vision and abdominal pain which is common in children    
 (ii)  The striking features are those of salt and water depletion, with loss of 
skin tone, furred tongue, cracked lips, tachycardia, hypotension and reduced intra 
ocular pressure. 
 (iii)  Cold extremities, tachycardia, air hunger (Kussmaul breathing), acetone 
odour in breath.  
 (iv)  Hypothermia, confusion, drowsiness and coma.    
2. Hypoglycaemia 
 It is the fall of blood glucose levels below 50-60mg/dl at which level 
symptoms occur in normal persons. Development of symptoms depends on the 
prevailing blood glucose levels and individual susceptibility.  
Symptoms of hypoglycaemia 
 Autonomic symptoms like palpitation, sweating, tremors, anxiety.  
 Neuroglycopenic symptoms: tiredness, dizziness, drowsiness, difficult to 
concentrate and dysphasia. 
 Lethargy, coma, convulsions  
 Permanent brain damage. 
 Sudden death due to cardiac arrhythmias („dead in bed‟ syndrome). 
3. Cardiovascular system 
 Macroangiopathy 
 Microangiopathy 
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4. Ocular complication 
 Diabetic Cataract 
 Diabetic Retinopathy 
 Glaucoma develops in 6% cases. 
5. Renal complications 
 Renal arteriosclerosis. 
 Pyelo nephritis - This is very common and may lead to chronic renal failure. 
 Micro albuminuria 
 Papillitis, Necroticans- The renal papillae will show necrosis, ultimately 
leading to viaemia. 
 Kimmelstiel – Wilson syndrome (K.W. syndrome)  
 This is develops in average 10 years duration clinically patient will present 
feature of nephritic syndrome.  
6. Diabetic neuropathy 
 This is an early and common complication affecting 39% of diabetic patients. 
Metabolic neuropathy develops due to hyperglycaemia and this subsides with proper 
control of Diabetes.  
 Peripheral neuritis (30%) 
 Autonomic imbalance 
 Diabetic amyotrophy 
 Charcot‟s joint 
7. Sexual and Genital Complications 
 Impotence and frigidity may develop erectile dysfunction in males is 
particularly important.  Balanitis and Balanoposthitis are common complications in 
males.  These are due to secondary infection as urine contains heavy amount of sugar 
and nitrogenous materials. Leucorrhoea may develop in females. 
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8. Pulmonary complications 
 Tuberculosis is very common in diabetes other infective complications like 
pneumonia, bronchopneumonia, pleurisy etc. 
9. Effect on pregnancy and neonates 
 There may be miscarriages and abortions, toxaemias of pregnancy, hydramios 
etc Herculian child may be born of diabetic mothers due to secretion of excess of 
growth hormone. 
10. Diabetic Foot 
 The Foot is a frequent site for complications in patients with diabetes, so foot 
care is particularly important. Tissue necrosis is common reason for hospital 
admission in diabetics may end in amputation.     
TREATMENT 
ANTI-DIABETIC DRUGS 
INSULIN
 [28]
 
 1. Insulin was first isolated from the Pancreas in 1922 by Banting and Best. 
Insulin is a polypeptide containing two chains of amino acids linked by disulfide 
bridges having molecular weight of 5808.        
 2. It is synthesized in the endoplasmic reticulum of the β cells as Preproinsulin 
that give rise to Proinsulin which undergoes peptic cleavage to form Insulin and C-
peptide. C-peptide connects  and β chains.      
 3.The half-life of insulin in the circulation in humans is about 5 minutes and 
cleared from circulation within 10-15 minutes and stored in beta cell granules and 
discharged into interstitial fluid under appropriate stimulus, enters portal circulation 
and liver traps 50-60% and remaining enter peripheral circulation. It is degraded by 
enzyme Insulinase in liver, in the kidneys and muscles. 
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Preparations of insulin 
 Insulin preparation differs in their source and duration of action. Based on the 
source they may be classified as bovine, porcine and human insulins.            
                                               
           Figure 1:- Insulin 
Table 3:- Insulin types 
Conventional insulin  
 Short and rapid 
acting 
 
 Intermediate acting 
 
 Long acting 
Regular  
Semilente 
Lente 
Isophane insulin(NPH) 
Ultralente 
Protamine zinc insulin 
Highly purified insulins  
 Single peak insulin 
 
 Monocomponent 
insulins 
Regular 
Lente  
Regular  
Lente  
Human insulin Regular  
Lente 
Ultralente 
Isophane 
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Insulin analogs 
 Rapid acting 
 
 Long acting 
 
Insulin lispro 
Insulin aspart 
Insulin glargine 
Insulin detemir 
Insulin mixtures Combinations of 20-50-% regular 
with 80-50% NPH (Neutral 
Protamine Hagedorn) insulins. 
 
Insulin and its doses
[29]
 
Regular/plane insulin   -  SOLUBLE INSULIN 40 IU/ml 
LENTE INSULIN, ISOPHANE  
INSULIN, PROTAMINE ZINC       -   40 IU/ml inj for   sub-cutaneous use. 
INSULIN  
Highly purified regular  -  ACTRAPID MC-40,100 IU/ml inj 
Highly purified lente   -  LENTARD, MONOTARD MC 40 
Iu/ml 
Highly purified NPH   -  INSULATARD-40/ml 
Mixture of regular + NPH insulin -  MIXTARD 40IU/ml 
Human actrapid   - regular 40,100 IU/ml inj 
Human monotard   - Lente 
Human insulatard   -  NPH 
Human mixtard   -  Regular NPH 
Humalog100U/ml inj   -  NOVALOG 100 IU/ml inj, FLEXPAN 
100 IU/ml (30ml vial) 
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ORAL ANTIDIABETIC DRUGS
 [30]
 
The main disadvantage of insulin is the need for injection. The advance of oral 
hypoglycaemics came as a boon to millions of NIDDM patients with early and mild 
diabetes. Sulfonylureas were available in 1950s. We now have 5 groups of oral 
hypoglycaemics  
 sulfonylureas,  
 biguanides,  
 meglitinides,  
 alpha glucosidase inhibitors  
 Thiazolidinediones.  
Table 4:- Mechanism of action and adverse effects of oral antidiabetic drug 
                  Mechanism of action and adverse effects of oral antidiabetics 
Oral antidiabetics Major mechanism Adverse effects 
Sulfonylureas ↑ insulin release from 
pancreas 
↑ tissue sensitivity to 
insulin 
Hypoglycaemia 
Cholestatic jaundice 
Disulfiram like reaction 
Biguanides  ↓ hepatic gluconeogenesis 
↑ tissue sensitivity  insulin 
Diarrhea, metallic taste, 
rarely lactic acidosis 
Meglitinides  ↑ insulin release from 
pancreas 
Hypoglycaemia 
 
Thiazolidinediones ↑ glucose transport into 
tissues 
↓ hepatic gluconeogenesis 
Weight gain, oedema, may 
precipitate CCF, risk of 
hepato toxicity  
α glucosidase inhibitors ↓ glucose absorption 
↓ hydrolysis of 
disaccharides 
Flatulence, diarrhoea, 
abdominal distension 
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Status of anti-diabetic drugs 
For the patients with IDDM, insulin is the only treatment as there is insulin 
deficiency due to destruction of β cells. Sulphonylureas need functional β cells for 
their action and therefore are not useful in IDDM. Uncomplicated NIDDM patients 
not controlled by diet and exercise are given oral hypoglycaemics. Mild NIDDM 
patients with recent onset diabetes, age above 40 years at onset of diabetes, obese with 
fasting sugar less than 200 mg/dl are candidates for oral hypoglycaemics. 
Some of the other Siddha drugs used for diabetes mellitus 
 Navalkottai Chooranam    
 Seenthil Chooranam 
 Sirukurinchan Chooranam    
 Kompupagal Chooranam 
 Thiripala Chooranam     
 Navathanya Chooranam 
 Santhiraganthi Chooranam    
 Maruthampattai kashayam 
 Atthiyathi kashayam     
 Aanandhabairava Mathirai 
 Mahalinga Mathirai     
 Sanjeevi kirutham 
 Meghaadi Kuligai     
 Karpoorathi Mathirai 
 Abragha parpam      
 Naga parpam 
 Velvanga parpam     
 Kaanda sendooram 
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3.3.  PHARMACEUTICAL REVIEW 
Pharmaceutics is a discipline of pharmacy that deals with the process of 
turning a new chemical entity to be used safely and effectively by the patients.  
  Siddha pharmaceutics has very minute chemical processes in it. It has several 
chemical processes like purification of raw substances, grinding them with herbal 
juices for several days and subjecting the ground material to fire by way of putam 
process. Medicines prepared according to the above methods undergo several 
chemical changes. 
Siddha medicines are classified into internal medicines (32) and external 
medicines (32). The drug taken for dissertation is in the form of Mathirai. Other 
names of Mathirai are Kuligai, Urundai, and Vattam. Mathirai comes under the 
category of internal medicines.
 [7b]
  
Purification of the drugs included 
Purification of the drugs is mainly done to remove the toxicities, impurities 
like soil, dust, clay present in the drugs. Also the drugs when subjected to heat like 
roasting or soaked in liquids undergo certain chemical reactions such as oxidation of 
toxic substances to non-toxic, reduction of some poisonous chemicals to non-
poisonous ones or undergo enzymatic reactions. In these ways, not only the toxicities 
and impurities are removed but also enhanced the potency of the drugs. 
Concept and Terminology of pills 
It is a pill prepared from a finely ground paste of drugs. The term Mathirai is 
the most fitting category of medicines as besides indicating the form of medicine that 
is pills. It also means that the minimal dosage unit is one pill (Mathirai means 1 unit). 
Preparation of Mathirai includes various processes like, extraction of juices, making 
decoction, preparing powders, grinding pastes and rolling into pills or pressing into 
tablets. The raw drugs are dried in the sun or shade and the drugs which are aromatic 
are to be roasted separately.  The raw drugs are purified and grounded separately, then 
the compounded drug be grounded in a mortar for the prescribed period with the 
addition of prescribed juices and decoctions. If green drugs are to be added they 
should be made into fine paste before being used. Vegetable drugs which require 
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frying are fried and powdered. However, scented herbal drugs like cinnamon leaves 
and cloves, cinnamon bark are dried only in shade as otherwise their volatile oil are 
lost by drying. 
The individual drugs should be separately weighed after being powdered and 
then taken in the prescribed ratio. After the pill mass has been prepared by following, 
the processes outlined in the recipe, it is convenient to roll it into long uniform pencils 
and then cut into bits of uniform length to give suitable pill weight and then rolling a 
pill from each piece. This is a fast process to prepare uniform pills as pinching and 
rolling every time is invariably a tiresome, tedious and time consuming messy 
process. The pill mass when rolled between the fingers should not stick. This is the 
correct consistency for rolling into pills. The pills should be always dried in a warm, 
dry shady place and never under the sun because volatile matters in the pills are easily 
lost and photochemical breakdown of active principles are faster in sunlight of the 
tropics.  If the pill mass sticks to the fingers, a speck of ghee may be smeared on the 
fingers. Pills should be well dried in shade
 [31]
. 
Storage and Usage 
Almost all the Mathirai contain highly active ingredients. Hence they should be 
preserved in well stopper glass vials with relevant labels and instructions. If the 
Mathirai lose their natural shape, colours, smell, taste etc, it is not advisable to 
consume them. If properly stored, we can keep them for a year. 
 Preparation of Mathirai in Manufacturing Units 
In the manufacturing unit, Chooranam is compressed into tablets. Tablets are 
unit forms of solid medicinal substances with or without suitable diluents prepared by 
compressing and they are mostly discoid in form. Binders like Gum acacia, lubricants 
like liquid paraffin and disintegrators like Talcum powder are used. Chooranam is 
first prepared according to the above procedures. Then the ingredients are mixed with 
in the form of granules before compressing as tablets. Too much fine powder refuses 
to form satisfactory tablets and so they must be mixed with some adhesive substances 
or binders such as gum acacia. To prevent the sticking of the tablets to the punches 
and dyes a lubricant like liquid paraffin is added. If the tablet is to dissolve quickly, a 
disintegrator like talcum powder is added 
[32]
. 
 REVIEW OF LITERATURE 
 
36 
ANTI DIABETIC ACTIVITY OF LINGA MATHIRAI 
                Shelf life of the drugs 
The shelf life of the drugs depends on the effectiveness of the preparation. The 
efficacy, smell, taste and appearance of the drugs gradually change as time goes on 
resulting in reduced potency thereby the desired effect is not attained. But some drugs 
appear to be good externally in spite of reduced efficacy. So they should not be 
considered for consumption and should be discarded. The shelf life of Mathirai is 1 
year. According to recently published guidelines by Ayush, the shelf life period of 
Mathirai is 2 years.  Also the following are the analytical parameters of specifications 
of Mathirai
 [33]
. 
Table 5:- Testing parameters for Mathirai-AYUSH guidelines 
[34]
 
S.No Tests 
  1 Description, Colour, Odour 
  2 Weight Variation 
  3 Disintegration Time (Not more than 15 minutes) 
  4 Identification TLC/ HPTLC/GLC 
  5 Assay 
  6 Test for heavy/toxic metals 
Mercury 
Arsenic 
Cadmium 
Lead 
    7 Microbial Contamination 
Total Bacterial count 
Total Fungal count 
     8 Test for specific pathogen 
E.coli 
Salmonella species 
Pseudomonas aeruginosa 
Streptococcus aureus 
    10 Test for aflatoxins B1, B2, G1, G2 
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 Traditional tests for Mathirai  
 Characters : 
 Non sticky on rolling. 
 No cracks over the surface after drying. 
 Shall be rolled uniformly over the plane surface.  
Based on these characters the drug is assessed as the appropriate one for 
medication. 
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3.4.  PHARMACOLOGICAL REVIEW 
PHARMACOLOGICAL STUDY OF ANTI-DIABETIC ACTIVITY IN 
ANIMAL MODELS 
Models for insulin dependent diabetes 
1. Chemically induced diabetes 
It is the most commonly used animal model of the diabetes mellitus. It is 
classified into three categories that include agents that 
 Specifically damage the β-cell 
 Cause temporary inhibition of insulin production 
 Decrease the efficacy of insulin in target tissues 
 In general chemicals in the first category are of interest as they reproduce 
lesions resembling IDDM
 [35]
. 
2. Alloxan – induced diabetes 
 Alloxan is a cyclic urea analog and it was reported to produce permanent 
diabetes in animals. 
Mechanism of action 
 The mechanism by which it induces diabetes is not very clear. Alloxan is 
highly reactive molecule that is readily reduced to diuleric acid, which is then auto 
oxidized back to alloxan resulting in the production of free radicals. These free 
radicals damage the DNA of the β cells and cause cell death. Second mechanism 
proposed for alloxan is its ability to react with protein SH group, especially the 
membrane proteins like glucokinase on the β cells; finally resulting in cell necrosis 
however, there are major species differences in response to alloxan
 [36]
.  
Procedure 
Animal models                                     Dose  
Rabbits (2 to 3 kg)    –  150 mg /kg 
Rats of wistar (150-200gm)   _  100-175mg/kg 
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Male beagle dogs (15-20kg)  –   60mg/kg 
Monkeys     –  65-200mg/kg 
 All the animals which are administered with alloxan receive glucose and 
regular insulin for one week and food ad libitum. Then single daily dose of 28 IU 
insulin is administered. There is a triphasic change in the blood glucose level. At first 
there is a hyperglycemia at 2 hrs, then hypoglycemic phase at 8 hrs and finally an 
increase at 24 hrs. 
3. Streptozotocin(STZ) - induced diabetes 
 STZ (2-deoxy-2-(3-methyl-3-nitrosourea) 1-D-glucopyranose) is a broad 
spectrum antibiotic produced from the Streptomyces achromogens. The Diabetogenic 
activity of STZ was first described by Rakieten
 [37]
. 
Mechanism of causing β cell damage 
 By process of methylation  
 Free radical generation  
 Nitric oxide production  
Procedure 
 STZ induces diabetes in all species of animals. 
Animal model                                      Dose   
Rats    - 50-60mg/kg 
Mice   - 175-200mg/kg 
Dogs   - 15mg/kg 
 After administration of the STZ the blood glucose level shows the triphasic 
change. Hyperglycemia at 1 hr, followed by hypoglycemia for 6hrs, and there is a 
stable hyperglycemia by 24-48 hrs. 
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4. Hormone induced diabetes 
 Dexamethasone, a long acting glucocorticoid is used to produce diabetes. 
Dexamethasone is administered to the rats in the dose of 2-5 mg/kg twice daily over a 
number of days. 
5. Diabetes induced by the viral agents 
Viruses are thought to be one of the etiologic agents for IDDM. Viruses may 
produce Diabetes mellitus by 
 Infecting and destroying of β-cells in pancreas. 
 A less infecting or cytologic variant producing a comparable damage by 
eliciting immune auto reactivity to the β-cells. 
 Viruses producing systemic effect, not directly affecting β-cells. 
Various numbers of viruses are used to induce diabetes. They are RN picorno virus, 
coxsackie-B4 (CB4), mengo – 2T, encephalomylocarditis (emc-d and m variants), 
double stranded RNA viruses, reovirus and lymphocytic choriomeningitis virus 
(LMCV). Primary isolates of these human pathogenic agents are generally not 
pancreatotrophic or ilytic to mouse b-cells and must be adapted for growth either by 
inoculation into suckling mice or by passage in cultured mouse β-cells [38]. 
6. Surgically induced diabetes 
Surgical removal of all or parts of the pancreas induce diabetes; in partial 
pancreatectomy more than 90% of the organ is removed to produce diabetes. 
Depending on the amount of intact pancreatic cells, diabetes may range in duration 
from a few days to several months. Total removal of the pancreas results in an insulin 
dependent form of diabetes, and insulin therapy is required to maintain experimental 
animals. The portion of the pancreas usually left intact following a subtotal pancreatic 
resection is typically the anterior lobe or a portion thereof
 [39]
. 
 The use of pancreatectomy in combination with chemical agents, such as 
alloxan and STZ, produces a stable form of Diabetes mellitus in animals, such as cats 
and dogs, that does not occur when each procedure is applied an dependently. The 
combination therapy reduces the organ damage associated with chemical induction 
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and minimizes the interventions, such as enzyme supplementation, necessary to 
maintain a pancreatectomized animal. 
7. Insulin antibodies-induced diabetes 
Giving bovine insulin along with CFA to guinea pigs produces anti-insulin 
antibodies. Intravenous injection of 0.25-1.0 ml guinea pig anti-insulin serum to 
rats induces a dose dependent increase in blood glucose levels up to 300 mg%. This 
unique effect to guinea pig anti-insulin serum is due to neutralization of endogenous 
insulin by the insulin antibodies. It persists as long as the antibodies are capable of 
reacting with insulin remaining in the circulation. Slow i.v. infusion or i.p. injection 
prolongs the effect for more than a few hours. However, large doses and prolonged 
administration are accompanied by ketonemia, ketonuria, glycosuria and acidosis and 
are fatal to the animals. After lower doses, the diabetic syndrome is reversible after a 
few hours
 [40]
. 
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    4. MATERIALS AND METHODS 
4.1.  PREPARATION OF THE DRUG 
Selection of drug 
 The trial drug “Linga Mathirai” were  prepared as per Siddha literature “Skitcha 
rathina deepam.” 
Ingredients 
Lingam (Cinnabar)    -  1 Palam (35gm) 
Sivanar vembu (Indigofera aspalathoides)  - 5 Palam (175gm) 
Naabi (Aconitum ferox)   -  1 Palam (35gm) 
 Nal Ennai (Gingelly oil)   -  5 Palam (175gm) 
Collection of the drugs 
 The crude drugs such as Cinnabar, Sivanar vembu, Naabi were procured from 
Ramasamy chettiyar Raw Drug Stores at Parry‟s, Chennai. 
 Gingelly oil prepared by traditional method (Chekku) was purchased from nearby 
oil store in Aminjikarai, Chennai. 
Identification and Authentication 
 All the raw drugs were identified and authenticated by Botanist and experts of 
Gunapadam Department (Pharmacology) at Government Siddha Medical College, 
Arumbakkam, Chennai.  
The specimen samples of the identified raw drugs were preserved in the 
laboratory of P.G Gunapadam for future references. 
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Method of purification 
Lingam  
Lingam (35 gm) was soaked in Cow‟s milk (30 ml) in the mud plate for one day.  
The next day it was soaked in lemon juice (30 ml) in the same mud plate for one day.  On 
third day it was washed thoroughly with pure water and dry it to get purified Cinnabar 
[41a]
. 
Naabi 
  The root was treated with cow‟s urine (30 ml) for three days, the urine has been 
renewed every day
 [41b]
. 
Method of preparation 
 Aconitum ferox (35 gm) had grounded well with water and made as paste, which 
was used to seal the 35 gm cinnabar. Then Indigofera aspalathoides of 175gm had also 
grounded with water made as paste and seal the above. The seal was covered by silk cloth 
kept it in sunlight for two hours. The gingelly oil (175 ml) was poured in iron pan, the 
above sealed one was fried until the gingelly oil has evaporates completely. Then the 
seals are removed, the cinnabar was grounded with boiled rice gruel of 1ml for three 
hours, then rolled it as pills.
 [43]
 
Preservation 
 The medicine was preserved in a clean, air tight container. 
Administration of the drug 
Form of the medicine   : pills 
Route of administration  : Enteral 
Dose     : 1 pills 
Time of administration  : 2 times a day 
Indication    : Diabetes and Polyuria.  
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INGREDIENT: 
                      
             Fig 2.1: Red sulphide of mercury               Fig 2.2: Indigofera aspalathoides 
 
         Fig 2.3: Aconitum ferox 
 
       Fig 2.4 : Gingilly oil 
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Preparation of Linga Mathirai 
      
         Fig: 3.1. Sealed with silk cloth                 Fig: 3.2. Fired with gingelly oil 
                  
   Fig:3.3. Seal opened after processed         Fig:3.4. Grinding 
           
Fig:3.5. Final form of Mathirai          Fig 4: Rolled pills of  Mathirai 
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4.2.  STANDARDISATION OF THE DRUG 
World Health Organization (WHO) has appreciated the importance of medicinal 
plants for public health care. The process of evaluating the quality and purity of herbo 
mineral drugs by means of various parameters like physical, chemical and biological 
observation is called standardization. Standardization of the this drug comes under the 
following categories 
 Physio-chemical analysis 
 Phyto chemical analysis 
 Bio chemical analysis 
ORGANOLEPTIC EVALUATION 
The Organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odour, size etc. 
1. Colour examination  
Ten tablets were taken into watch glasses and positioned against white back 
ground in white tube light. Its colour was observed by naked eye and results are noted. 
2. Odour examination 
Ten numbers of tablets were smelled individually. The time interval among two 
smelling was kept two minutes to overturn the effect of previous smelling. Odour of  
Linga Mathirai was noted in results table.  
3. Size examination 
The diameter of ten tablets was measured by Vernier caliper. The mean value of 
diameter was noted. 
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4.2.1.  PHYSICO-CHEMICAL INVESTIGATION 
Physico‐chemical studies like total ash, water insoluble ash, acid Insoluble ash, 
loss on drying at 105°C and pH were done at, Central Research Institute, Chennai. 
Solubility Test 
A pinch of the sample (Linga Mathirai) was taken in a dry test tube and shaken 
well with distilled water. A little amount of the sample (Linga Mathirai) is shaken well 
with con. Hcl and then Con. H2SO4. Solubility was observed.  
Determination of Total Ash 
About 2 g of the ground drug (Linga Mathirai) was accurately weighed in a silica 
dish and incinerated at a temperature not exceeding 450º until it was free from carbon, 
cooled and weighed. The percentage of ash with reference to the air-dried drug was 
calculated. 
Determination of Water Soluble Ash 
Total ash was heated up to 600
0
C with 25 ml of distilled water for 10 minutes and 
the residue was ignited in the furnace to get a constant weight. And the weight was 
calculated. 
Determination of Acid Insoluble Ash 
The ash obtained was boiled for 5 minutes with 25 ml of dilute hydrochloric acid 
and insoluble matter was collected in an ash-less filter paper, washed with hot water and 
put up in flames to constant weight. The percentage of acid-insoluble ash with reference 
to the air dried drug was noted.   
Determination of Moisture Content (Loss on Drying)  
This procedure was done to determine the amount of volatile matter in the drug. A 
sample of 10 gram of the drug (Linga Mathirai) was placed in a tarred evaporating dish 
after accurately weighting without preliminary drying. The dish was dried at a 
temperature of 105
0
C for about 5 hours and again weighed. The drying and weighing 
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procedure was repeated again and again until the difference between two successive 
weights was not more than 0.25%. And the weight was calculated. 
pH value 
Potentiometrically pH value was determined by a glass electrode and a pH meter. 
The pH of the Linga Mathirai was written in results column.  
Tablet Disintegration test 
Each Linga Mathirai was placed in each of the six tubes of the basket present in 
the disintegration apparatus. The apparatus was operated by using water as the immersion 
fluid maintained at 35-39 °C. At the end of the 30 min, the basket is lifted from the fluid 
and the state of the tablet is observed. The disintegration time of Linga Mathirai was 
recorded
 [44]
. 
Weight variation test 
It was carried out to make sure that, each number of tablets contains the proper 
amount of drug. The test was carried out by weighing the 20 tablets individually using 
analytical balance, then the average weight was calculated, and comparing the individual 
tablet weights to the average
 [45]
. 
The percentage of weight variation is calculated by using this formula.  
 % of wt. variation =    Individual wt. – Average wt.  x 100 
 Average wt. 
   Table 6:- Weight variation limits of Tablets (IP) 
Average weight of tablets Maximum percentage of weight 
difference allowed 
80 mg or less ±10.0 
Between 80 mg and 250 mg ±7.5 
250 mg and more ±5.0 
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4.2.2.  BIO-CHEMICAL ANALYSIS 
The bio-chemical analysis was done to identify the acid and basic radicals present 
in the Linga Mathirai. 
Preparation of extract 
 5g of Linga Mathirai was taken in a 250 ml clean beaker and 50 ml of distilled 
water was added, boiled well and allowed to cool and filtered in a 100 ml volumetric 
flask and made up to 100 ml with distilled water.  
PRELIMINARY BASIC AND ACIDIC RADICAL STUDIES  
TEST FOR BASIC RADICALS 
1. Test for Potassium 
 To a pinch of the Linga Mathirai 2 ml of sodium nitrate and 2 ml of cobalt nitrate 
solution in 30% glacial acetic acid was added and observed for the presence of yellow 
precipitate. 
2. Test for Calcium 
To 2 ml of Linga Mathirai extract, 2 ml of 4% ammonium oxide solution was 
added and observed for the formation of white precipitate. 
3. Test for Magnesium 
To 2ml of Linga Mathirai extract, drops of sodium hydroxide solution was added 
and watched for the appearance of white precipitate. 
4. Test for Ammonium 
To 2ml of Linga Mathirai extract few ml of Nessler's reagent and excess of 
sodium hydroxide solution are added for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the Linga Mathirai, made as paste 
and introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour.  
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6. Test for Iron (Ferrous) 
The Linga Mathirai extract was treated with Conc. HNO3 and ammonium 
thiocyanate and waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the Linga Mathirai extract drops of sodium hydroxide solution was 
added and observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the Linga Mathirai extract sodium hydroxide was added in drops 
and changes are noted.  
9. Test for Lead 
To 2 ml of Linga Mathirai extract 2ml of potassium iodide solution was added 
and noted for yellow coloured precipitate.  
10. Test for Copper 
a. A pinch of Linga Mathirai was made into a paste with con. Hcl in a watch glass 
and introduced into the non-luminous part of the flame and noted for blue colour 
appearance. 
b. To 2 ml of Linga Mathirai extract excess of ammonia solution was added and 
observed for the appearance of blue coloured precipitate.  
11. Test for Mercury 
 To 2m1 of the Linga Mathirai extract sodium hydroxide solution was added and 
noted for yellow precipitate formation.  
12. Test for Arsenic 
 To 2 ml of the Linga Mathirai extract 2ml of sodium hydroxide solution was 
added and observed for brown or red precipitate and noted.  
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TEST FOR ACID RADICALS 
1. Test for Sulphate 
 To   2 ml of the Linga Mathirai extract 5% of barium chloride solution was added 
and observed for the appearance of white precipitate.  
2. Test for Chloride 
 The Linga Mathirai extract was treated with silver nitrate solution and observed 
for the appearance of white precipitate. 
3. Test for Phosphate 
         The Linga Mathirai extract was treated with ammonium molybdate and conc. 
HNO3 and observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
        The Linga Mathirai extract was treated with conc.Hcl and observed forth 
appearance of effervescence. 
5. Test for Fluoride & Oxalate 
To 2ml of Linga Mathirai extract 2ml of dil.acetic acid and 2ml calcium chloride 
solution was added and heated and watched for cloudy appearance. 
6. Test for Nitrate 
 To 1 gm of the Linga Mathirai, copper turnings was added and again conc.H2SO4 
was added, heated and the test tube was tilted vertically down  and observed for any 
changes. 
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4.2.3.  MICROBIAL LOAD 
AVAILABILITY OF BACTERIAL LOAD 
Enumeration of bacteria by plate count – agar plating technique 
 The plate count technique is one of the most routinely used procedure because of 
the enumeration of viable cells by this method
[46]
.  
PRINCIPLE 
 This method is based on the principle that when material containing bacteria is 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies, therefore are the same as the number of organisms 
contained in the Linga Mathirai. 
DILUTION 
 A small measured volume of Linga Mathirai are mixed with a large volume of 
sterile water called the diluent or dilution blank.  Dilution are usually made in multiples 
of ten. A single dilution is calculated as follows: 
              Volume of the sample 
   Dilution  =  
     Total volume of the sample and the diluents 
 
REQUIREMENTS 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
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PROCEDURE 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the Linga Mathirai extract into a 
9 ml dilution blank labelled 10
-1
 thus diluting the sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat this procedure till the sample have been diluted 10,000,000 times 
using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are to 
used for each dilution. 
8. Add approximately 15 ml of the nutrient medium, melted and cooled to 450c, 
to each petri dish containing the diluted Linga Mathirai extract. Mix the 
contents of each dish by rotating gently to distribute the cells throughout the 
medium. 
9. Allow the plates to solidify. 
10.  Incubate these plates in an inverted position for 24-48 hours at 370c. 
OBSERVATION 
 Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
 Calculate the number of bacteria per ml of the original suspension as follows: 
                Number of colonies (average of 3 repleates) 
 Organisms per millimetre =  
              Amount of plated × dilution 
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4.2.4.  SOPHISICATED INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red) 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   : MIR 450-4000 cm-1 
Resolution   : 1.0 cm-1  
Sample required : 50 mg, solid or liquid. 
It was the preferred method of infrared spectroscopy. FT-IR was an important and 
more advanced technique. It was used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It was an excellent tool for quantitative analysis
 [47]
. 
FT-IR was the most advanced and the major advantage was its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated. 
In FT-IR infrared was passed from a source through a sample (Linga Mathirai). 
This infrared was absorbed by the sample(Linga Mathirai) according to the chemical 
properties and some are transmitted. The spectrum that appears denotes the molecular 
absorption and transmission. It forms the molecular fingerprint of the Linga Mathirai. 
Like the finger print there was no two unique molecular structures producing the same 
infrared spectrum. It was recorded as the wavelength and the peaks seen in the spectrum 
indicates the amount of material present
 [48]
.  
SEM (SCANNING ELECTRON MICROSCOPE) 
 In scanning electron microscope high-energy electron beam was focused through 
a probe towards the sample (Linga Mathirai). Variety of signals was produced on 
interaction with the surface of the sample (Linga Mathirai). This results in the emission 
of electrons or photons and it was collected by an appropriate detector
 [49]
.  
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The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample
 [50]
. 
ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer  (ICP) 
Principle 
 An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). The intensities are proportional to the 
concentrations of analyses in the aqueous sample. The quantification was an external 
multipoint linear standardization by comparing the emission intensity of an unknown 
sample with that of a standard sample. Multi-element calibration standard solutions are 
prepared from single- and multi element primary standard solutions. With respect to other 
kinds of analysis where chemical speciation was relevant (such as the concentration of 
ferrous iron or ferric iron), only total essential concentration was analysed by             
ICP-OES 
[51]
. 
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Application 
 The analysis of major and minor elements in solution  Linga Mathirai. 
Objectives 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements probes 
the outer electronic structure of atoms 
Mechanism  
 In plasma emission spectroscopy (OES), a Linga Mathirai solution was presented 
into the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light was collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum of 
its essential wavelengths. Within the spectrometer, this deflected light was then collected 
by wavelength and amplified to yield an strength of  measurement that can be converted 
to an elemental concentration by comparison with standardization values
 [52]
. 
 The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 
5300 DV. 
Sample preparation 
  100 mg Linga Mathirai was occupied in a clean, dry test tube. To this, 3 
ml Nitric acid was added and mixed well and allowed for few minutes untill the reactions 
were completed. And then, 25 ml of Refined water, was added to prepare digested 
solution. The digested  Linga Mathirai  solution was shifted into plastic containers and 
labeled properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical College, 
Chennai-106. 
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FTIR (Fourier Transform Infrared Spectroscopy): 
 
Fig 5.1:   FTIR INSTRUMENT 
 
Fig 5.2:  FTIR MECHANISM 
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SEM - SCANNING ELECTRON MICROSCOPE: 
 
      Fig 5.3: SEM INSTRUMENT 
 
Fig 5.4:   SEM MECHANISM 
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ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY 
 
 
 
     
 
 
  
        Fig 5.5: ICP-OES ANALYSER (Perkin Elmer Optima 5300 DV) 
 
 
 
 
Fig 5.6: Mechanism of ICP-OES analyser 
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4.3.  TOXICOLOGICAL STUDIES 
ACUTE ORAL TOXICITY – OECD GUIDELINES – 423  
INTRODUCTION 
The acute toxic class method was a stepwise procedure with the use of 3 animals 
of a single sex per step. Depending on the mortality and the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute toxicity 
of the test substance. Morbid animals or animals obviously in pain or showing signs of 
severe and enduring distress shall be humanely killed, and are considered in the 
interpretation of the test  results  in  the  same  way  as  animals  that  died  on  test.  The 
method allows for the determination of an LD50 value only when at least two doses 
result in mortality higher than 0% and lower than 100%. 
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co – operation and Development, Guideline-423. 
The experimental protocol was approved by the Institutional Animal Ethical 
Committee (IAEC) under CPCSEA (Approval no: IAEC/XLIV/26/CLBMCP/2014) at 
C.L.Baid Metha College of pharmacy, Thuraipakkam, Chennai. 
Animal: Healthy wistar albino female rat weighing 200–220 gm 
PRINCIPLE 
It was the principle of the test that based on a stepwise procedure with the use of a 
minimum  number  of  animals  per  step,  information  was  obtained  on  the  acute 
toxicity  of  the  test  substance  to  enable  its  classification.  The substance was 
administered orally to a group of experimental animals at one of the defined doses.  The 
substance was tested using a stepwise procedure, each step using three animals of a single 
sex. Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e.; − no further testing was needed – dosing of three 
additional animals with the same dose – dosing of three additional animals at the next 
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higher or the next lower dose level. The method will enable a judgment with respect to 
classifying the test substance to one of a series of toxicity classes
 [53]
.   
Studied carried out at three female rats under fasting condition, signs of toxicity 
was observed for every one hour for first 24 hours and every day for about 14 days from 
the beginning of the study. 
METHODOLOGY  
Selection of animal species 
The preferred rodent species was rat, although other rodent species may be used.  
Healthy young adult animals of commonly used laboratory strain Swiss albino rat were 
obtained from Animal house of king‟s institute, Guindy, Chennai. Females should be 
nulliparous and non-pregnant.  Each animal at the commencement of its dosing should be 
between 8 and 12 weeks old and its weight should fall in an interval within ±20 % of the 
mean weight of the animals.  The studies were conducted in the animal house of C.L.Baid 
Metha College of pharmacy, Thuraipakkam, Chennai. 
Housing and feeding conditions  
   The  temperature  in  the  experimental  animal  room  should  be  22ºC  (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not  exceed  
70% other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hrs dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals may be 
grouped and tagged by dose, but the number of animals per cage must not interfere with 
clear observations of each animal.   
Preparation of animals   
   The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions. 
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EXPERIMENT PROCEDURE 
Administration of doses 
Linga Mathirai was prepared as per the classical Siddha literature was suspended 
in 2% CMC with uniform mixing and was administered to the groups of Wistar albino 
rats. It was given in a single oral dose by gavages using a feeding needle. Animals were 
fasted prior to dosing. Following the period of fasting, the animals were weighed and 
then the test substance was administered. After the substance has been administered, food 
was withheld for a further 3-4 hours. The principle of laboratory animal care was 
followed. Observations were made and recorded systematically and continuously 
observed as per the guideline after substance administration.  
The visual observations included skin changes, mobility, aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 hours prior to the administration of the test suspension. Finally, 
the number of survivors was noted after 24 hours and these animals were then maintained 
for a further 14 days and observations made daily. The toxicological effect was assessed 
on the basis of mortality.  
Number of animals and dose levels 
Since this Linga Mathirai has been under practice for long time and likely to be 
non-toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried out 
with 6 animals (3 animals per step). Duration of study is 48 hours and evaluation of 14 
days  
Duration of Study: 48 hours 
Evaluation:  14 Days 
Limit test 
The limit test was primarily used in situations where the experimenter has 
information indicating that the test material was likely to be nontoxic, i.e., having toxicity 
only above regulatory limit doses. A limit test at one dose level of 2000 mg/kg body 
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weight was carried out with three animals per step. The test substance-related mortality 
was not produced in animals, so further testing at the next lower level need not be carried 
out.  
Observations 
 The animals were observed individually after dosing at least once during the first 
30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug.  
 It was observed daily thereafter for a total of 14 days, except when they needed to 
be removed from the study and killed humanely for animal welfare reasons or are 
found dead. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hours following drug administration on day 1 of the experiment and daily twice thereafter 
for 14 days.   
b. Body weight 
Body weights will be recorded at Day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed from 
the study) will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals 
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Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, number 
of animals displaying signs of toxicity, the number animals found dead during the test or 
killed for humane reasons, a description and the time course of toxic effects and 
reversibility, and necroscopic findings. 
Test substance and Vehicle  
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing Linga Mathirai with 2% CMC solution and it was found 
suitable for dose accuracy.  
Justification for choice of vehicle 
The vehicle selected as per the standard guideline was pharmacologically inert 
and easy to employ for new drug development and evaluation technique
 [54]
. 
REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF LINGA MATHIRAI  
ON RATS – (OECD-407 guidelines) 
Justification for Dose Selection 
 The results of acute toxicity studies in Wistar albino rats indicated that Linga 
Mathirai was non-toxic and no behavioral changes was observed up to the dose level of 
2000 mg/kg body weight. On the basis of body surface area ratio between rat and human, 
the doses selected for the study were100mg/kg, 200 mg/kg and 400 mg/kg body weight. 
The oral route was selected for use because oral route was considered to be a proposed 
therapeutic route
 [55]
. 
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Preparation and administration of dose 
Linga Mathirai at three doses respectively was suspended in 2 ml of 2% CMC in 
distilled water. It was administered to animals at the dose levels of 100, 200 and 400 
mg/kg. The test substance suspensions were freshly prepared every day for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
 Ten rats (Five Male and Five Female) were in each group randomly divided into 
four groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 
days to laboratory conditions prior to the initiation of treatment. Each animal was fur 
marked with picric acid. The females were nulliparous and non-pregnant. 
OBSERVATIONS 
Experimental animals were kept under observation throughout the course of study 
for the following  
Body Weight  
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated.  
Clinical signs 
 All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality 
All animals were observed twice daily for mortality during entire course of study. 
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Functional Observations 
At the end of the 4
th
 week exposure, „sensory reactivity‟ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), „motor reactivity‟ and „grip 
strength‟ were assessed. 
Laboratory Investigations 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. On 28th 
day of the experiment, 24 hours urine samples were collected by placing the animals in 
the metabolic cage with free access to tap water but no feed was given.  
 The urine was free from fecal contamination. Toluene was used as a preservative 
while collecting the sample. The sediments present in the urine were removed by 
centrifugation and the collected urine was used for biochemical estimations. On 29th day, 
the animals were fasted for approximately 18 hours, then slightly anesthetized with ether 
and blood samples were collected from the retro-orbital plexus into two tubes: one with 
EDTA for immediate analysis of haematological parameters, the other without any 
anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the 
serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
Haematological Investigations 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV).  
Biochemical Investigations 
Serum was used for the estimation of biochemical parameters. Samples of control 
and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. Activities 
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of glutamate oxaloacetate transaminase/ Aspartate aminotransferase (GOT/AST), 
glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and alkaline 
phosphatase were estimated as per the colorimetric procedure.  
Urine analysis 
Urine samples were collected on end of treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology.  
Necropsy 
All the animals were sacrificed on day 29. Necropsy of all animals was carried 
out and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs 
were recorded. The relative organ weight of each animal was then calculated as follows; 
     Absolute organ weight (g) 
Relative organ weight = ___________________________________________ ×100 
    Body weight of animal on sacrifice day (g) 
Histopathology 
 Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 
10% formalin for 24 hours and washed in running water for 24 hours. Samples were 
dehydrated in an auto technique and then cleared in benzene to remove absolute alcohol.  
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds. 
It was followed by microtome and the slides were stained with Haematoxylin-eosin.  The 
organs included heart, kidneys, liver, ovary, pancreas, brain, spleen and stomach, of the 
animals were preserved they were subjected to Histopathological examination. 
Statistical analysis 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnet‟s multi comparision test using a computer software programme 
GRAPH PAD INSTAT-3 version. 
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4.4.  PHARMACOLOGICAL ACTIVITY 
4.4.1. ANTI-DIABETIC ACTIVITY OF LINGA MATHIRAI 
Screening the drug Linga Mathirai against Streptozotocin (STZ) induced Diabetes in 
Wistar albino Rats
 
Experimental Animals  
 The animals were divided into 5 groups each constituting 6 rats. Group I were 
normal rats, Group II were STZ (55 mg/kg b.w., i.p) induced diabetic rats. Group III STZ 
(55 mg/kg b.w., i.p) induced diabetic rats were treated with Glibenclamide 5mg/kg 
b.w/p.o Group IV STZ (55 mg/kg b.w., i.p) induced diabetic rats were treated with Linga 
Mathirai200mg/kg b.w/ p.o Group V STZ (55 mg/kg b.w., i.p) induced diabetic rats were 
treated with Linga Mathirai 400mg/kg b w/p.o for 28 days. 
Methodology 
Induction of Diabetes 
 Diabetes was induced in male Wistar albino rats aged 2–3 months (180–200 g 
body weight) by intra peritoneal administration of STZ (single dose of 55 mg/kg b.w) 
dissolved in freshly prepared 0.01 M citrate buffer, pH 4.5. 
  After injection the animals had food and water ad libitum and were given 5% 
glucose in their drinking water for the first 24 hours to counter any initial hypoglycemia. 
The development of diabetes was confirmed after 72 hours of the Streptozotocin 
injection. After 72 hours of STZ injection under mild anesthesia the blood was withdrawn 
from the tip of the tail of each rat and the blood glucose level was analyzed. Animals with 
more than 250 mg/dl was considered as diabetic.
 
 
 Fasting blood glucose levels was measured before the administration of extracts. 
The blood glucose levels were checked on 0th, 7th, 14th, and 21st day of the treatment 
period. Blood was collected from snipping of the rat tail. Blood glucose levels were 
measured
 [56]
. 
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Experimental Design 
 Diabetic rats were divided into three groups with six animals in each group. 
 
Table 7:- Experimental design 
 
 
 
 
 
 
 
 
 
 
Blood collection 
 All the experimental rats were fasted overnight and the blood was withdrawn 
through puncturing retro orbital sinus on the 5
th
 day, 15
th
 day and 20
th
 day of post 
induction period to determine blood glucose level by GOD-POD kit method. The change 
in body weight was observed throughout the treatment period in experimental animals 
[57]
 
Statistical Analysis 
 All the values were expressed as Mean ± S.D. The differences between control 
and treatment groups were tested for significance using ANOVA followed by Dunnet‟s t 
test. P<0.05 were considered significant. 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (55 mg/kg ) 
Group III Diabetic control- Glibenclamide (5 mg/kg) 
Group IV Diabetic control- Linga Mathirai 200mg/kg  
Group V Diabetic control-  Linga Mathirai400mg/kg  
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4.2.2. ANTI – DYSLIPIDEMIC  ACTIVITY 
TRITON WR 1339 INDUCED DYSLIPIDEMIA FOR LINGA MATHIRAI 
Experimental protocol 
Total number of groups:  4 
Number of animals / group:  6 
Sex:     Both 
Strain:     Wistar albino rats 
Body Weight:    200 – 250 g 
Surfactant administration 
Surfactant:    10% Triton WR – 1339 
Route of administration :  Intravenously  
Vehicle:     Saline 
Test drug administration 
Vehicle:     2% CMC 
Route of administration :  Oral 
Drug dose:    Linga Mathirai - 200 mg/kg b.wt 
Procedure 
 Wistar rats weighing 200–350 g were starved for 18 hours and then injected 
intravenously with 10% Triton WR 1339 (isooctyl-polyoxyethylene phenol).  
Phase I: Serum cholesterol levels increase sharply 2–3 times after 24 hours. 
Phase II: The hypercholesterolemia decreases nearly to control levels within the next 24 
hours.    
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 The test drug (Linga Mathirai)  employed or the solvent for the controls are 
administered simultaneously with the Triton injection or 22 hours thereafter. Serum 
cholesterol analyses are made 6, 24, and 48 hours after Triton injection.  
Mechanism 
 The mechanism of the Triton induced hypercholesterolemia in phase I was 
thought to be due to increased hepatic synthesis of cholesterol through the ability of 
Triton to interfere with the uptake of plasma lipids by the tissues. Drugs interfering with 
cholesterol biosynthesis were shown to be active in phase I, while drugs interfering with 
cholesterol excretion and metabolism were active in phase II
 [58]
. 
Experimental design 
 The animals were divided into three groups with six animals in each group. 
Group I  →   Normal control administered with 2% CMC 
Group II  →   Dyslipidemic control received 10% Triton WR – 1339 
Group III  →   Standard administered with Lovastatin (10 mg/kg b.wt) and triton 
Group IV  →   Test drug Linga Mathirai - 200mg/kg b.wt 
 All the animals after 72 hours of triton injection (ie. after inducing dyslipidemia) 
the respective treatment was continued for 7 days. 
Collection of blood 
 On the 8th day the blood was collected by retro orbital sinus puncture, under mild 
ether anesthesia. The collected samples were centrifuged for 10 minutes. Then serum 
samples were collected and it is used for various biochemical experiments. Then animals 
were sacrificed and collected the liver. 
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Biochemical analysis 
 Total cholesterol 
 High-density lipoprotein 
 Low-density lipoprotein 
 Very low density lipoprotein 
 Triglycerides 
4.2.3. ANTI-OXIDANT ACTIVITY OF LINGA MATHIRAI (In-Vitro study) 
FREE RADICAL SCAVENGING ACTIVITY 
DPPH Assay (2, 2-diphenyl -1-picrylhydrazyl) 
 The radical scavenging activity of extracts was determined by using DPPH assay 
according to Chang et al [2001].The decrease in the absorption of the DPPH solution 
after the addition of an antioxidant was measured at 517 nm. Ascorbic acid (10mg/ml 
DMSO) was used.  
Principle 
 1, 1-diphenyl-2-picryl hydrazyl was a stable free radical with red colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-A) 
can be written as, 
   DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability
 [59]
. 
Reagent preparation 
0.1mm DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of ethanol.  
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Procedure 
 Different volumes (2.5µl - 40µl) of plant extracts were made up to a final volume 
of 40µl with DMSO and 2.96ml DPPH (0.1mM) solution was added. The reaction 
mixture incubated in dark condition at room temperature for 20 minutes. After 20 
minutes, the absorbance of the mixture was read at 517nm. 3ml of DPPH was taken as 
control. 
Calculation 
                                 Control – test  
                            % inhibition =                               ˟ 100 
                                                                 Control 
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 5. RESULTS AND DISCUSSION 
 Many studies have been carried out to bring the efficacy and potency of the 
drug Linga Mathirai. The study includes literary collections, organoleptic character, 
physicochemical, instrumental analysis, toxicological study and pharmacological 
study. The drug Linga Mathirai has been selected for Anti-Diabetic activity in 
reference with the text “Skitcha Rathina Deepam”. 
 Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the diabetes. 
 Gunapadam review brings the effectiveness of the ingredients present in the 
drug for Anti-diabetic, Anti-dyslipidemic and Anti-oxidant properties. 
 Botanical aspect explains the identification, morphological description, 
microscopic character, macroscopic character, active principle and medicinal 
uses of the plants.  
 Siddha and modern aspect of disease explains about clinical features and 
complication of Diabetes mellitus and also explains adverse effect of drugs 
used in modern aspect.  
 Pharmaceutical review describes about the purification, preparation, 
administration of   Mathirai and explains about its self life properties.  
 The pharmacological review explains about the methodology of Anti-Diabetic 
Activity and the drugs used. 
STANDARDIZATION OF THE TEST DRUG 
 Standardisation of the drug is more essential to derive the efficacy, potency of 
the drug by analysing it by various studies. Following are the results of 
physicochemical. Physical characterisation and estimation of basic and acidic radicals 
have been done and tabulated.  
 Toxicological results of the drug and pharmacological activity of the drug 
were derived. Its result has been tabulated and interpretation was made below. Thus it 
is to give a complete justification to bring the effectiveness of the trial drug Linga 
Mathirai. 
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ORGANOLEPTIC CHARACTER 
Table 8 :- Physical characterization of Linga Mathirai 
S.NO Parameter Results 
1 Colour Brick red 
2 Odour Odourless 
3 Consistency Hard 
4 Shape Spherical 
5 State of matter Solid 
6 pH 7.6 
6 Total ash 1.379% 
7 Water soluble Ash 0.294% 
8 Acid insoluble Ash 0.871% 
9 Loss on Drying at 105
0
C 0.483% 
10 Disintegration time 23 min 
 
Discussion 
 pH of Linga Mathirai is 7.6. It is slightly alkaline in nature. The alkaline 
medium enhance the mineral storage in order to buffer, reduces aging process, 
increase the utilization of oxygen level in body [60].  
 The amount of minerals and earthy materials present in the drug are 
represented by Total ash value. The value of Linga Mathirai is 1.379%, it 
determines the purity of the drug. 
 Water soluble ash represents easy facilitation of diffusion and osmosis 
mechanism. Here the value of Linga Mathirai is 0.294% will denotes its 
diffusion capacity. 
 The amount of siliceous matters in the drug are represented by acid insoluble 
ash value. The acid insoluble ash value of Linga Mathirai is 0.871%, which 
determines the superior quality of the Linga Mathirai. 
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 The moisture content of the drug is determined by loss on drying. These will 
also indicates stability and shelf life of the drug. Here the percentage denotes 
the higher stability of the Linga Mathirai.  
 Linga Mathirai is formulated according to classical Siddha text, disintegration 
indicates the better solubility and absorbability of drug. 
Weight variation test 
Table 9:- Uniformity weight variation test result of Linga Mathirai 
S.No. Weight of each 
Mathirai (mg) 
% of weight 
variation 
Maximum weight 
variation with in 
±7.5% 
Maximum weight 
variation with in 
±15.0% 
1 138 5.423% Yes Yes 
2 137 4.660% Yes Yes 
3 132 0.840% Yes Yes 
4 130 -0.687% Yes Yes 
5 139 6.187% Yes Yes 
6 135 3.132% Yes Yes 
7 126 -3.743% Yes Yes 
8 129 -1.451% Yes Yes 
9 125 -4.507% Yes Yes 
10 133 1.604% Yes Yes 
11 127 -2.979% Yes Yes 
12 128 -2.215% Yes Yes 
13 136 3.896% Yes Yes 
14 124 -5.271% Yes Yes 
15 129 -1.451% Yes Yes 
16 131 0.076% Yes Yes 
17 135 3.132% Yes Yes 
18 120 -8.326% No Yes 
19 122 -6.799% Yes Yes 
20 126 -3.743% Yes Yes 
 Average : 130.95 g 
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Discussion 
 Average weight of the Mathirai was noted as 130.95g. Out of 20 tablets tested, 
19 tab of them lies within ±7.5% weight variation (1 tab above the limit) and 
all 20 tab lies within ±15% weight variation.   
 According to the limits of weight test cited in the Indian pharmacopoeia, 
Linga Mathirai passed the Uniformity weight test.  
 The uniformity test resembles uniformal distribution of this tablet helps good 
absorbtion and distribution.  
TRADITIONAL TEST FOR PILL 
  Character                                                                        Inference 
 Non sticky on rolling      + 
 No cracks over the surface after drying   + 
 Shall be rolled uniformly over the plane surface  +  
BIO CHEMICAL ANALYSIS 
Basic radicals 
Table 10:- Results for Basic radicals 
S.NO Parameter Observation Result 
1 Test for Potassium Yellow colour 
precipitate 
+ve 
2 Test for Calcium - -ve 
3 Test For Magnesium - -ve 
4 Test For Ammonium - - ve 
5 Test For Sodium - -ve 
6 Test for Iron (Ferrous) - -ve 
7 Test For Zinc - -ve 
8 Test For Aluminium - -ve 
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9 Test For Lead - - ve 
10 Test for Copper - - ve 
11 Test For Mercury - - ve 
12 Test for Arsenic - - ve 
Interpretation 
The basic radical test shows the presence of Potassium, and absence of heavy metals. 
Potassium 
 The K+ inwardly rectifier channel (KIR) is one of the two sub-units of the 
pancreatic islet ATP-sensitive potassium channel complex (IKATP). It has a key role 
in glucose-stimulated insulin secretion and thus is a potential candidate for a genetic 
defect in Type II (non-insulin-dependent) diabetes mellitus [61]. 
Acid radical 
Table 11:- Results for Acid radicals 
S.NO Parameter Observation Result 
1 Test for Sulphate Formation of white 
precipitate 
+ ve 
2 Test for Chloride - - ve 
3 Test for Phosphate - - ve 
4 Test for Carbonate - - ve 
5 Test for fluoride &oxalate - - ve 
6 Test For Nitrate - - ve 
 
Interpretation 
The acidic radicals test shows the presence of sulphate.  
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MICROBIAL LOAD 
Availability of bacterial and fungal load in Linga Mathirai 
Bacteria 
                            
          Fig 5.1. 10-4 dilution                      Fig 5.2. 10-6 dilution 
 
Fungi 
 
                             
           Fig 5.3. 10-2 dilution                    Fig 5.4. 10-3 dilution   
      
 The contaminated toxins present in the drug will produce adverse effect, 
which develops unwanted diseases. They are unfit for humans [62]. 
 Here, the contamination of Linga Mathirai have been examine by bacterial 
and fungal load. 
 Total bacterial load in 10-4 dilution is 4 and in 10-6 dilution is Nil. 
 Total fungal load in 10-2 dilution is Nil and in 10-3 dilution is Nil.  
 The load of bacterial and fungal are within the limits of WHO norms. 
 
  
 RESULTS AND DISCUSSION 
 
80 
ANTI DIABETIC ACTIVITY OF LINGA MATHIRAI 
INSTRUMENTAL ANALYSIS 
   FTIR  
 
Table 12:- FTIR Result of Linga Mathirai 
CHARACTERISTIC 
ABSORPTION(S)  (cm
-1
) 
FUNTIONAL GROUPS 
3420 
Alcoholic group Normal ‘‘polymeric’’ OH stretch 
Amine group of N-H Bending 
2917 Alkane C-H Stretch, Acid group of O-H stretch 
1628 
Alkene group of C=C stretch, Amide group of N-H 
Bending 
1032 
 
Alkyl Halide C-F stretch, Ether C-O stretch, Ester C-O 
stretch 
 
DISCUSSION 
 The above table shows the presence of  Alcoholic group, Amine group, 
Alkane group and Alkyl Halide are the organic functional groups, also Ether 
and Ester group of Carbonyl functional groups.  
 OH group has higher potential towards inhibitory activity against 
microorganisms.  
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SCANNING ELECTRON MICROSCOPY (SEM)                             
                                             
 
Fig 6.1. SEM image of 10 µm 
 
 
Fig 6.2. SEM image of 2 µm 
Scanned electron microscope image of Linga Mathirai 
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DISCUSSION 
  SEM picture shows Nano and micro particle (Ultra fine particle) size of the 
sample. And the picture shows various sizes of the particles like 152nm, 177nm, 
220nm, 229 and 299nm. 
 Sizes ranging from 179nm to 304nm. The surface of the sample grains is 
uniformly arranged. These are micro particles presenting as 152nm, 177nm, 220nm, 
229nm and 299nm. The difference in morphology as evident from the micrograph is 
due to presence of chemicals in the samples. 
Micro particles-significance   
 Micro particles are defined as particulate dispersion or solid particles with a 
size in the range of 100-1000nm in diameter. 
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
 They control the release of drug during the transportation and at the site of 
localization, alters drug distribution in the body and subsequent clearance of 
the drug so as to achieve increased drug therapeutic efficacy thereby bio-
availability and reduced side effects [63]. 
ICP-OES 
 
Table 13:- ICP-OES Result of Linga Mathirai 
S. no Elements Detected levels 
1. Sulphur  52.514 mg/L 
2. Potassium 20.821 mg/L 
3. Calcium 12.120 mg/L 
4. Phosphorus 08.541 mg/L 
5. Mercury 0.674 mg/L 
6. Iron 0.380 mg/L 
7. Sodium 03.110 mg/L 
8. Arsenic BDL 
9. Cadmium BDL 
10. Nickel BDL 
11. Lead BDL 
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DISCUSSION 
 From the above results, the heavy metals like Arsenic, Cadmium and Lead are 
below detectable limit. 
 Mercury was in permissible limit. 
 Hence, the safety of the drug Linga  Mathirai is ensured. 
 Also, the drug contains Calcium, Iron, Potassium, Sodium, Sulphur and 
Phosphorus. 
Calcium [64] 
 Calcium was associated with the lower risk of Diabetes mellitus 
 Calcium is necessary in normalising the glucose tolerance. 
 Abnormal regulation of intracellular calcium affecting both insulin sensitivity 
and insulin release. 
Iron 
 The heme containing enzymes such as catalase and peroxidase protect cell 
against potentially damaging highly reactive species. 
 Iron is essential for many numbers of biological functions such as growth, 
reproduction, healing and immune function. 
Sodium 
 Recently sodium glucose cotransporter 2 reabsorbs most of the glucose filtered 
by the kidneys. Thereby, lowering the blood glucose levels and have been 
approved as new anti hyperglycemic drug. [65].  
 A synergistic effect of all these Calcium, Iron, Potassium, Sodium, 
Phosphorus and Sulphur increases the potency of the drug against Diabetes mellitus. 
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TOXICOLOGY STUDIES 
ACUTE ORAL TOXICITY IN RATS– OECD 423 
 Wistar albino rat was treated with the test drug Linga Mathirai of single dose 
of 2000mg/kg in 2%CMC as suspention. This study was conducted as per the OECD 
guidelines. The result of acute toxicity of Linga Mathirai has been tabulated below. 
Table 14:- Observation in acute toxicity study 
Group Day 
Body weight Normal 
Assessments of posture Normal 
Signs of Convulsion 
Limb paralysis 
Absence  (-) 
Body tone Normal 
Lacrimation Absence 
Salivation Absence 
Change in skin color No significant colour change 
Piloerection Normal 
Defecation Normal 
 
Sensitivity response Normal 
Locomotion Normal 
Muscle gripness Normal 
Rearing Mild 
Urination Normal 
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Table 15:-  Dose finding experiment and its behavioural Signs of Toxicity for Linga Mathirai 
 
1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response  7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia15.Lacrimation 16. 
Exophthalmos 17.Diarrhoea   18. Writhing   19 Respiration   20.  Mortality 
Discussion 
In the acute toxicity study, the rats were treated with different concentration of 
Linga Mathirai from the range of 5mg/kg to 2000mg/kg which did not produce signs 
of toxicity, behavioral changes, and mortality in the test groups as compared to the 
controls when observed during 14 days of the acute toxicity experimental period. 
 These results showed that a single oral dose of the extract showed no 
mortality of these rats even under higher dosage levels indicating the high margin of 
safety of this extract.    In acute toxicity test the Linga Mathirai was found to be non 
toxic at the dose level of 2000mg/ kg body weight.  
RESULTS OF SUB-ACUTE ORAL TOXICITY 28-DAYS REPEATED DOSE 
STUDY IN RATS 
 Wistar albino rat was treated with the test drug Linga Mathirai for 28 days  
repeated dose of 100mg/kg and 200 mg/kg in 2% CMC as suspention. This study was 
conducted as per the OECD guidelines. The result of sub acute toxicity of Linga 
Mathirai has been tabulated below 
 
  
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000 + - - - - + - - - - - - - - - - - - + - 
 RESULTS AND DISCUSSION 
 
86 
ANTI DIABETIC ACTIVITY OF LINGA MATHIRAI 
Body Weight 
Table 16:- Effect of Linga Mathirai on Body Weight of rats 
Dose 
(mg/kg/day) 
Days 
0 7 14 21 28 
Control 120.59±0.9
2 
122.79±0.8
7 
123.52±1.1
8 
127.24±1.1
2 
131.25±1.0
5 
100 126.02±1.1
5 
129.86±1.5
7 
132.94±1.5
1 
135.77±0.7
6 
136.78±1.1
4 
200 127.49±1.2
4 
130.92±0.8
9 
133.83±1.5
3 
135.98±0.9
2 
138.81±0.8
1 
             Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant, 
     **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
Organ weight 
Table 17:- Effect of Linga Mathirai on Organ weight of rats 
Organ Control 100 mg/kg 200 mg/kg 
Liver (g) 5.240.14 5.1±0.24 5.2±0.3 
Heart (g) 0.700.05 0.65±0.12 0.72±0.11 
Lung (g) 1.780.25 1.66±0.42 1.73±0.4 
Spleen (g) 0.740.07 0.68±0.17 0.78±0.08 
Brain (g) 1.430.18 1.2±0.41 1.45±0.36 
Kidney (g) 0.700.05 0.61±0.11 0.69±0.09 
      Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant,                          
            **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
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Haematological parameters 
Table 18:- Effect of Linga Mathirai on Haematological parameter of rats 
Parameter Control 100mg/kg 200 mg/kg 
RBC(x 10
6
/mm
3
) 8.29±0.43 9.25±0.46 9.61±0.40 
PCV (%) 49.66±0.77 50.92±0.73 52.22±1.06 
Hb (%) 15.13±0.39 15.69±0.37 15.86±0.24 
WBC(x 10
3
/mm
3
) 11.75±0.85 10.35±0.34 9.46±0.34 
Neutrophils (%) 23.29±0.73 26.91±1.24 28.13±1.14 
Eosinophills (%) 4.1±0.23 3.43±0.52 2.70±0.64 
Lymphocyte (%) 85.5±0.46 85.78±0.21 86.5±0.41 
Platelets(x 10
3
/mm
3
) 425.73±1.35 427.02±0.98 424.54±2.19 
      Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant,     
         **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
Biochemical parameters 
Table 29:- Effect of Linga Mathirai on Biochemical parameter in rats 
Parameters Control 100 mg/kg 200 mg/kg 
Glucose (mg/dl) 108.63±0.81 107.14±0.56 105.95±0.78 
BUN (mg/dl) 22.06±1.55 24.45±1.86 25.70±2.39 
Creatinine (mg/dl) 0.85±0.07 0.83±0.06 0.76±0.03 
SGOT (U/L) 74.35±1.23 72.93±1.15 71.43±1.24 
SGPT(U/L) 27.07±0.84 25.49±1.17 23.94±0.97 
ALP (U/L) 104.63±1.14 103.43±1.69 102.71±0.71 
Protein (g/dl) 8.58±0.68 8.24±0.53 7.66±0.43 
Albumin (g/dl) 5.34±0.40 4.77±0.31 4.11±0.14 
Total Cholesterol ( mg/dl) 93.21±1.16 92.01±0.64 90.02±1.02 
Triglycerides ( mg/dl) 52.58±1.56 55.99±1.46 64.23±1.59 
        Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant, 
      **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
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Urine Parameter 
Table 20:- Effect of Linga Mathirai on Urine parameter in rats 
Parameter 
Control 100 mg/kg 200 mg/kg 
Colour Yellow Yellow Yellow 
Transparency Clear Clear Turbid 
Specific gravity 1.01 1.02 1.04 
pH 7.2 7.4 6.9 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood Absent Absent Absent 
RBCs Nil Nil Nil 
Epithelialcells Nil Nil Nil 
Casts Nil Nil Nil 
 
        
DISCUSSON 
Body weight 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 28 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal. 
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Organ weight 
 The weights of organs recorded did not show any significant differences in the 
treatment and the control group indicating that Linga Mathirai was not toxic to 
kidney, liver and spleen  
Haematological investigation 
 There was no significant changes were observed in hemoglobin (Hb), red 
blood cell (RBC), white blood cell (WBC), packed cell volume (PCV), Erythrocyte 
sedimentation rate (ESR) in all the treated groups as compared to respective control 
groups. 
 The increase and decrease in the values obtained were all within the normal 
biological and laboratory limits. 
Biochemical investigation 
 No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits.  
Urine analysis 
Urine analysis data of control group and the test groups of animals taken on 
28
th
 day showed no abnormal results. 
 The dose selected for the sub acute toxicity study was 100mg, 200mg/kg of  
Linga Mathirai. All the animals were free of intoxicating signs throughout the dosing 
period of 28 days.  
 No physical changes were observed throughout the dosing period.  
 No mortality was observed during the whole experiment.  
 No abnormal deviations were observed.  
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Fig 7. HISTOPATHOLOGY SLIDES: 
 
          Control   Linga Mathirai 100m  Linga Mathirai 200mg 
 
KIDNEY 
                          
              
LIVER 
                         
 
SPLEEN 
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DISCUSSION 
 From histopathological examinations, the slides of animal’s organ did not 
reveal abnormalities. 
From the acute and sub-acute toxicity studies the drug produced some 
significant changes .But the values were found within normal limits. So the drug 
Linga Mathirai was nontoxic and safe. 
 Thus the safety of the drug is revealed so that it can be administered for long 
time without any side effects. 
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PHARMACOLOGY STUDIES 
ANTI DIABETIC ACTIVITY 
Blood glucose level 
Table 21:-Effect of Linga Mathirai on Blood glucose level in Streptozotocin 
induced diabetic rats 
Group  Blood glucose (mg/dl) 
Day – 0 Day – 7 Day – 14 Day – 21 Day – 28 
Normal control 89.40±1.13 87.53±1.32 92.75±2.87 85.13±2.43 94.70±2.11 
Diabetic Control 
106.22±1.14 240.9±1.66 275.3±1.41  287.8±1.32 295.4±1.20 
Diabetic rats + 
Glibenclamide 
103.5±1.45 151.0±1.32** 142.05±1.33 114.3±1.48 102.3±1.45** 
Diabetic rats 
+Linga Mathirai 
100mg/kg 
99.13±1.22* 220.5±1.00 190.2±2.17 161.8±1.20 129.5±1.44 
Diabetic rats 
+Linga Mathirai 
200mg/kg 
94.23±1.38* 179.8±1.34 158.04±1.92 131.03±1.76 114.8±1.87* 
        Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant, 
       **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
 
Chart 1:- Anti Diabetic activity of Linga Mathirai 
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Body weight in Streptozotocin induced diabetic rats 
Table 22:- Effect of Linga Mathirai on Body weight in Streptozotocin induced 
diabetic rats 
Group 
No. 
Treatment Body weight (g) on post induction days 
Initial 5
th
 day 15
th
 day 20
th
 day 
I Normal control 163.65±2.52 165.39±3.21 166.97±2.58 168.95±2.45 
II Diabetic Control 159.59±2.78 157.70± 3.34 129.30±2.10 120.20±2.33 
III Diabetic rats + 
Glibenclamide 
161.30±3.26 163.40 ± 2.77* 167.8±3.26 174.70 ± 2.37** 
IV Diabetic rats + 
Linga Mathirai 
200mg/kg 
160.90±4.78 164.20 ± 3.23 171.20 ± 4.86* 176.20± 4.89** 
      Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant,  
           **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
 
 
Chart  2:- Body weight in Diabetic induced rats  
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DISCUSSION 
Anti Diabetic activity 
 The Anti-Diabetic Activity of the test drug Linga Mathirai has been estimated 
in the streptozotocin induced diabetes in Wistar albino rat. 
 Administration of the streptozotocin effectively induced diabetes mellitus in 
the animal model which is known by the increased glucose level. 
 STZ, slightly cytotoxic agent of pancreatic beta cells, selectively destroys the 
pancreatic insulin secreting beta cells, thus leaving less active cells and resulting in 
diabetes mellitus. Thus it is widely used to induce diabetes in animal models. It also 
interferes with cellular metabolic oxidative mechanisms [66]. 
 Oral administration of the test drug Linga Mathirai taken in the dose of 
200mg/kg showed significant decrease in the sugar level.  
 The possible mechanism by which the test drug Linga Mathirai brings about a 
decrease in the blood sugar may be by potentiation of the insulin effect of plasma by 
increasing either the pancreatic secretion of insulin from β-cells of the islets of 
Langerhans or its release.  
 Linga Mathirai a Siddha herbal formulation used in the treatment of diabetes 
shows significant reduction in the sugar level which was studied by inducing diabetes 
in the animal model Wistar albino rat by streptozotocin.  
Body weight changes 
 Body weight of the animal models in this study was also monitored. There is 
decrease in the body weight of the animal treated with the control. Whereas the 
animal treated with Linga Mathirai shows a significant improvement in the body 
weight. Thus the trial drug not only reduced the sugar level but also maintains the 
body weight in Diabetes Mellitus.  
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ANTI DYSPIPIDEMIC ACTIVITY 
Table 23:- Effect of Linga Mathirai on lipid profile of Triton induced 
Dyspipidemia in rats 
Lipid parameters Group-I 
Normal 
control 
Group-II          
Triton control 
rats 
Group-III 
Dyspipidemic+
Lovastatin 
Group-IV 
Dyspipidemic+
Linga Mathirai 
TotalCholesterol 
(mg/dl) 
71.49±0.91 172.46±1.14 66.08±1.32 73.50±1.03 
 
HDL (mg/dl) 30.64±1.11 26.20±1.07 62.92±1.58** 73.4±1.29* 
LDL (mg/dl) 52.85±1.01 123.75±1.43 46.85±1.07 48.27±0.58* 
VLDL (mg/dl) 20.83±1.23 82.14±1.02 45.52±1.40** 52.21±1.50 
TGL (mg/dl) 64.45±0.76 124.78±1.93 55.81±1.40 55.46±1.39 
       Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant,    
   **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
 
 
Chart 3:- Anti Dyspipidemic activity 
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DISCUSSION 
 Diabetes mellitus (DM) is a group of metabolic diseases characterized by 
hyperglycemia, hypertriglyceridaemia and hypercholesterolaemia, resulting from 
defects in insulin secretion or action or both [67]. 
 In diabetes mellitus along with hyperglycemia there is dyspipidemia always 
accompanied representing risk factor for coronary heart disease and other 
complications. Deficiency in insulin or insulin resistance may be responsible for 
dyspipidemia. Insulin has a inhibiting action on the enzymes involved in biosynthesis 
of cholesterol. Therefore deficiency of insulin results in the increase in level of LDL, 
VLDL, TG, cholesterol and decrease in HDL. Dyspipidemia produces further 
vascular complications and increases the severity of diabetes [68]. 
 Anti-dyspipidemic activity of the test drug Linga Mathirai was conducted by 
Triton Wr 1339 induced dyspipidemia in animal model Wistar albino rats. The results 
were tabulated above.  
 The test drug Linga Mathirai of 200mg/kg b.wt showed significant changes in 
the lipid level. There is a significant decrease in the level of LDL, VLDL, TGL. There 
is a significant increase in the HDL also noted. The standard drug also showed the 
significant decrease in the LDL, VLDL, TG. But there is no significant increase in the 
HDL. 
 Hence this anti-dyspipidemic activity supports the anti-diabetic activity of the 
drug Linga Mathirai in giving an effective treatment of diabetes as a whole. 
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ANTI OXIDANT ACTIVITY 
 
Table 24:- Effect On Oxidative Stress by Linga Mathirai 
Sample 
concentration 
(µg/ml) 
Absorbance 
 
Percentage of 
Inhibition 
Drug Standard Drug Standard 
Control 0.5271 0.312 
 
- - 
1.25 0.3873 0.278 26.21 40.89 
2.50 0.3585 0.202 33.24 51.25 
5 0.3365 0.084 60.10 74.07 
10 0.2901 0.052 71.25 83.33 
20 0.2611 0.034 76.57 89.62 
*µg/ml: microgram per millilitre. Drug:   Linga Mathirai (1.25-20µg/µl). Standard: 
Ascorbic acid(10mg/mlDMSO) 
 
 
Chart 4:- Anti Oxidant activity 
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DISCUSSION 
 Anti-Oxidant study of the trial drug Linga Mathirai was conducted and the 
result has been given in the above table. The trial drug possesses significant Anti-
Oxidant property. 
 Oxidative stress is one of the major pathophysiology of the disease. Oxidative 
stress is associated with the increased production of reactive oxygen species and 
impaired antioxidant defense systems, which cause lipid peroxidation, alteration in 
antioxidant enzymes and impaired glutathione metabolism [69]. 
 In diabetes mellitus tissue damage is brought about mainly by the oxidative 
stress. There are certain enzymes involved in the Anti-Oxidant mechanism protecting 
the body from damage. The study shows the amount of the anti-oxidant enzymes 
increased significantly after the administration of the trial drug thus revealing its Anti-
Oxidant property. 
 Hence the test drug Linga Mathirai possesses rich Anti-Oxidant property. 
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6. CONCLUSION 
 The drug Linga Mathirai was selected to validate the safety and its efficacy 
for diabetes in animal model (Wistar albino rats). 
 The ingredients of the drug was identified and authenticated by Gunapadam 
experts. The drug was prepared as per classical Siddha literary procedure and 
subjected to various studies to reveal its potency and efficacy of the drug. 
 The Organoleptic character and physico chemical studies were made to 
standardization of the drug Linga Mathirai. From the above studies, the Linga 
Mathirai is standardized as per AYUSH guidelines. 
 The analysis of biochemical, instrumental was made to know the presence of 
active ingredients in the drug which is responsible for its activity. 
 Here, the biochemical analysis showed the presence of potassium, by its 
synergistic effect, the drug as activity against the disease. 
 In instrumental analysis, FTIR showed the peak values represents the 
functional groups responsible for its activity. SEM picture explained the particle size 
of the drug. In ICP-OES described about the absence of heavy metals and its 
permissible limits which showed the safety of the drug. 
 Toxicity studies revealed about the acute and sub acute toxicity effect of the 
Linga Mathirai  in the rat models. The drug showed no toxicity and mortality in both 
acute and sub acute toxicity. According to OECD guidelines, the haematological, 
biochemical parameters are investigated. There were no significant changes in the 
functional behaviour and in the normal values. Thus, it was greatly established the 
safety of the drug administrated for long time. 
 Pharmacological studies were done on the rat model for Anti diabetic, Anti- 
Dyslipidemic activity and In vitro study for Anti- oxidant activity. 
 In diabetes the main pathophysiology is increased oxidative stress which 
results in the tissue damage and it is the main reason for other complications. The 
anti-oxidant property of this drug is mainly due to the presence of phytochemicals 
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(flavonoids, phenols, etc.,) and other active ingredients which involve in scavenging 
the free radicals and prevents tissue damage and other complications. 
 In Anti diabetic activity, there was significant decreased blood glucose level 
and slightly increased body weight in the Streptozotocin induced Wistar albino rats. 
 In diabetes hyperglycemia is always accompanied with the dyslipidemia. 
Deficiency of insulin results in the increase in level of LDL, VLDL, TG, cholesterol 
and decrease in HDL. Dyslipidemia produces further vascular complications and 
increases the severity of diabetes. The drug showed significant decrease in the LDL 
and marked increase in the HDL than the standard drug. 
 In Anti dyslipidemic activity, showed significant decreased LDL, VLDL, TG, 
TC levels and marked increased HDL level in the triton WR-1339 induced 
dyslipidemic in Wistar albino rat models. 
 In Anti oxidant activity, there was significant effect of drug when compare to 
standard in DPPH assay. 
 Thus by surviving all the above factors, it is concluded that the drug Linga 
Mathirai is safe and potent drug against Anti diabetic and Anti-dyslipidemic activity 
with rich Anti oxidant activity. This will support the treatment and management of 
diabetes and its complication. In treating, the disease with this drug it has a synergistic 
effect of controls blood sugar level, lipid profile and also the oxidative stress brings a 
complete treatment of diabetes and its complication as a whole.     
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7. FUTURE SCOPE 
 The drug Linga Mathirai has its own potency in treating Diabetes mellitus in 
animal model which has been established in this study.  
 However, the mechanism of action by which Linga Mathirai produced its 
effect on decreasing the blood sugar level in experimental animals need to be 
evaluated in a scientific manner using specific experimental animal models and also 
multi-center clinical trials are required to understand the exact molecular mechanisms 
of action. So it could be used worldwide in treatment of Diabetes mellitus. 
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     8. SUMMARY 
 
 In the Siddha literature “Skitcha rathina deepam” the drug Linga Mathirai 
was selected for its Anti-diabetic, Anti-dyslipidemic and Anti-oxidant 
activities. 
 In this dissertation, Introduction explained about the Siddha concept, about the 
disease diabetes in Siddha and modern aspect, prevalence of diabetes, 
mortality and morbidity rate and role of the drug in treating diabetes. 
 The drug was prepared as per classical Siddha literature, the ingredients were 
identified and authenticated by Gunapadam experts. 
 In review of literature, many studies were carried out about the drugs botanical 
aspect, Gunapadam aspect. Pharmaceutical review enclosed about the 
preparation of drug and the pharmacological review established the 
methodologies. 
 The drug was subjected to various analysis such as physico chemical, 
biochemical and also instrumental analysis which provided the active 
ingredients present in the drug. 
 Toxicological study was made according to OECD guidelines showed the 
study of the drug. 
 Pharmacological studies were done to reveal the Anti-diabetic, Anti-
dyslipidemic activity in animal models and Anti-oxidant activity of Linga 
Mathirai in DPPH assay. 
 Results and discussion gave justifications to prove the potency of the drug. 
 Conclusion explained the synergistic effect of all active ingredients and 
activities that supports the study. 
 Thus, the herbo-mineral formulation Linga Mathirai is validated for its safety 
and efficacy for treating Diabetes mellitus, it would be a great drug of choice. 
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